###begin article-title 0
The right dose for every sex
###end article-title 0
###begin p 1
Communicated by T. Orr-Weaver
###end p 1
###begin p 2
###xml 188 198 188 198 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Drosophila</italic>
###xml 345 355 345 355 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Drosophila</italic>
###xml 426 436 426 436 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Drosophila</italic>
###xml 728 738 728 738 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Drosophila</italic>
Sex chromosomes in different organisms are studied as model systems for chromatin regulation of transcription and epigenetics. Similar to the female X in mammals, the male X chromosome in Drosophila is involved in the process of dosage compensation. However, in contrast to one of the mammalian female X chromosomes undergoing inactivation, the Drosophila male X is transcriptionally upregulated by approximately twofold. The Drosophila male X is a remarkable example for a specialized, transcriptionally hyperactive chromatin domain that facilitates the study of chromatin regulation in the context of transcription, nuclear architecture, and chromatin remodeling. In addition, the rich phenomenology of dosage compensation in Drosophila provides an opportunity to explore the complexities of gene regulation through epigenetic chromatin configurations, histone modifications, and noncoding RNAs. Male-specific lethal (MSL) factors constitute the MSL complex or dosage compensation complex and are important for transcription regulation of X-linked genes. Recent biochemical studies have identified a number of interesting factors that associate with the MSL complex including components of the nuclear pore complex and exosome subunits. Furthermore, global analysis of MSL complex binding showed that MSL complexes are enriched on genes with preferential binding to 3' end of genes. Taken together, these findings suggest a role of the MSL complex in transcription elongation, RNA processing, and/or nuclear organization.
###end p 2
###begin title 3
###xml 23 33 23 33 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Drosophila</italic>
Dosage compensation in Drosophila-a fascinating story
###end title 3
###begin p 4
Different numbers or types of sex chromosomes bring about the distinction between heterogametic and homogametic individuals. Unequal distribution of chromosomes normally results in dramatic changes in gene dosage that can lead to developmental defects or death. Therefore, in parallel with sex chromosomes, animals have evolved mechanisms that ensure equalization of gene expression levels between males and females. These processes evolved independently several times during evolution, and they are collectively termed dosage compensation. The mechanisms of dosage compensation vary largely between different organisms and involve different molecular factors. However, the common theme among all model systems of dosage compensation, which have been analyzed at the molecular level, is their regulation at the level of chromatin.
###end p 4
###begin p 5
###xml 239 262 239 262 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Drosophila melanogaster</italic>
###xml 272 276 272 276 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR13">1925</xref>
###xml 340 344 340 344 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR44">2006</xref>
###xml 350 360 350 360 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Drosophila</italic>
###xml 433 443 433 443 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Drosophila</italic>
###xml 589 590 589 590 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig1" ref-type="fig">1</xref>
###xml 716 720 716 720 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR1">2003</xref>
###xml 739 743 739 743 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR36">2004</xref>
###xml 765 769 765 769 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR63">2005</xref>
###xml 828 838 828 838 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Drosophila</italic>
###xml 911 934 911 934 <italic xmlns:xlink="http://www.w3.org/1999/xlink">male-specific lethality</italic>
###xml 956 960 956 960 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR9">1980</xref>
###xml 978 982 978 982 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR33">1975</xref>
###xml 1000 1004 1000 1004 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR46">1997</xref>
###xml 1007 1013 1007 1013 <label xmlns:xlink="http://www.w3.org/1999/xlink">Fig.&#160;1</label>
###xml 1036 1046 1036 1046 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Drosophila</italic>
###xml 1071 1081 1071 1081 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Drosophila</italic>
###xml 1216 1217 1216 1217 <bold xmlns:xlink="http://www.w3.org/1999/xlink">a</bold>
###xml 1419 1420 1419 1420 <bold xmlns:xlink="http://www.w3.org/1999/xlink">b</bold>
###xml 1013 1531 1013 1531 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="6">Dosage compensation in <italic>Drosophila</italic>. Dosage compensation in <italic>Drosophila</italic> involves an approximately twofold transcriptional upregulation of the single male X chromosome in comparison to female X chromosomes (<bold>a</bold>). This is mediated by an RNA/protein MSL complex or dosage compensation complex (DCC) which is composed of at least five proteins: MSL1, MSL2, MSL3, MOF, and MLE, and two noncoding RNAs roX1 and roX2 (<bold>b</bold>). The MSL complex is responsible for hyperacetylation of histone H4 lysine 16 (H4K16) on the male X chromosome</p>
###xml 1013 1531 1013 1531 <caption xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="6">Dosage compensation in <italic>Drosophila</italic>. Dosage compensation in <italic>Drosophila</italic> involves an approximately twofold transcriptional upregulation of the single male X chromosome in comparison to female X chromosomes (<bold>a</bold>). This is mediated by an RNA/protein MSL complex or dosage compensation complex (DCC) which is composed of at least five proteins: MSL1, MSL2, MSL3, MOF, and MLE, and two noncoding RNAs roX1 and roX2 (<bold>b</bold>). The MSL complex is responsible for hyperacetylation of histone H4 lysine 16 (H4K16) on the male X chromosome</p></caption>
###xml 1531 1531 1531 1531 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="anchor" xlink:href="412_2006_89_Fig1_HTML" id="MO1"/>
###xml 1007 1531 1007 1531 <fig xmlns:xlink="http://www.w3.org/1999/xlink" id="Fig1"><label>Fig.&#160;1</label><caption><p textid="6">Dosage compensation in <italic>Drosophila</italic>. Dosage compensation in <italic>Drosophila</italic> involves an approximately twofold transcriptional upregulation of the single male X chromosome in comparison to female X chromosomes (<bold>a</bold>). This is mediated by an RNA/protein MSL complex or dosage compensation complex (DCC) which is composed of at least five proteins: MSL1, MSL2, MSL3, MOF, and MLE, and two noncoding RNAs roX1 and roX2 (<bold>b</bold>). The MSL complex is responsible for hyperacetylation of histone H4 lysine 16 (H4K16) on the male X chromosome</p></caption><graphic position="anchor" xlink:href="412_2006_89_Fig1_HTML" id="MO1"/></fig>
###xml 150 161 <span type="species:ncbi:7227">fruit flies</span>
###xml 239 262 <span type="species:ncbi:7227">Drosophila melanogaster</span>
One of the prominent dosage compensation model systems, which has been genetically and biochemically studied, is the hyperactive X chromosome in male fruit flies. Moreover, dosage compensation as a general principle was first described in Drosophila melanogaster (Bridges 1925). In contrast to mammals (for a review, see Heard and Disteche 2006), in Drosophila females (XX), both X chromosomes are actively transcribed. Accordingly, Drosophila males (XY) have to increase their transcription from the single X chromosome about twofold to compensate for the different gene dosage (see Fig. 1). Molecular factors that have male-specific lethal (MSL) phenotype have been genetically identified (for reviews, see Akhtar 2003; Gilfillan et al. 2004; and Lucchesi et al. 2005). Most of the factors required for dosage compensation in Drosophila have been found in a series of genetic screens for mutants that exhibit male-specific lethality (Belote and Lucchesi 1980; Fukunaga et al. 1975; Hilfiker et al. 1997). Fig. 1Dosage compensation in Drosophila. Dosage compensation in Drosophila involves an approximately twofold transcriptional upregulation of the single male X chromosome in comparison to female X chromosomes (a). This is mediated by an RNA/protein MSL complex or dosage compensation complex (DCC) which is composed of at least five proteins: MSL1, MSL2, MSL3, MOF, and MLE, and two noncoding RNAs roX1 and roX2 (b). The MSL complex is responsible for hyperacetylation of histone H4 lysine 16 (H4K16) on the male X chromosome
###end p 5
###begin p 6
###xml 23 33 23 33 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Drosophila</italic>
###xml 58 68 58 68 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Drosophila</italic>
###xml 203 204 203 204 <bold xmlns:xlink="http://www.w3.org/1999/xlink">a</bold>
###xml 406 407 406 407 <bold xmlns:xlink="http://www.w3.org/1999/xlink">b</bold>
Dosage compensation in Drosophila. Dosage compensation in Drosophila involves an approximately twofold transcriptional upregulation of the single male X chromosome in comparison to female X chromosomes (a). This is mediated by an RNA/protein MSL complex or dosage compensation complex (DCC) which is composed of at least five proteins: MSL1, MSL2, MSL3, MOF, and MLE, and two noncoding RNAs roX1 and roX2 (b). The MSL complex is responsible for hyperacetylation of histone H4 lysine 16 (H4K16) on the male X chromosome
###end p 6
###begin p 7
###xml 118 126 118 126 <italic xmlns:xlink="http://www.w3.org/1999/xlink">maleless</italic>
###xml 138 139 138 139 <italic xmlns:xlink="http://www.w3.org/1999/xlink">m</italic>
###xml 138 139 138 139 <bold xmlns:xlink="http://www.w3.org/1999/xlink"><italic>m</italic></bold>
###xml 139 151 139 151 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ales absent </italic>
###xml 151 152 151 152 <italic xmlns:xlink="http://www.w3.org/1999/xlink">o</italic>
###xml 151 152 151 152 <bold xmlns:xlink="http://www.w3.org/1999/xlink"><italic>o</italic></bold>
###xml 152 158 152 158 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n the </italic>
###xml 158 159 158 159 <italic xmlns:xlink="http://www.w3.org/1999/xlink">f</italic>
###xml 158 159 158 159 <bold xmlns:xlink="http://www.w3.org/1999/xlink"><italic>f</italic></bold>
###xml 159 163 159 163 <italic xmlns:xlink="http://www.w3.org/1999/xlink">irst</italic>
###xml 406 407 406 407 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig2" ref-type="fig">2</xref>
###xml 424 428 424 428 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR57">1991</xref>
###xml 444 448 444 448 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR79">1993</xref>
###xml 637 641 637 641 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR23">1998</xref>
###xml 657 661 657 661 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR67">2000</xref>
###xml 678 682 678 682 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR68">2006</xref>
###xml 697 701 697 701 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR87">2000</xref>
###xml 716 720 716 720 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR90">2000</xref>
###xml 843 847 843 847 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR6">1997</xref>
###xml 863 867 863 867 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR66">1997</xref>
###xml 1006 1010 1006 1010 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR32">1999</xref>
###xml 1031 1035 1031 1035 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR65">2002</xref>
###xml 1051 1055 1051 1055 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR66">1997</xref>
###xml 1070 1074 1070 1074 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR90">2000</xref>
###xml 1231 1235 1231 1235 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR26">2006</xref>
###xml 1253 1257 1253 1257 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR27">2003</xref>
###xml 1273 1277 1273 1277 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR54">1999</xref>
###xml 1280 1286 1280 1286 <label xmlns:xlink="http://www.w3.org/1999/xlink">Fig.&#160;2</label>
###xml 1442 1447 1442 1447 <italic xmlns:xlink="http://www.w3.org/1999/xlink">green</italic>
###xml 1459 1465 1459 1465 <italic xmlns:xlink="http://www.w3.org/1999/xlink">orange</italic>
###xml 1498 1502 1498 1502 <italic xmlns:xlink="http://www.w3.org/1999/xlink">blue</italic>
###xml 1286 1629 1286 1629 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="8">MSL proteins are enriched on the male X chromosome. Polytene chromosomes from the male third instar larvae were immunostained with antibodies against MSL3 (<italic>green</italic>) and MSL2 (<italic>orange</italic>). DNA is visualized by Hoechst (<italic>blue</italic>). The figure illustrates that MSL proteins specifically recognize and colocalize on hundreds of sites on the male X chromosome</p>
###xml 1286 1629 1286 1629 <caption xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="8">MSL proteins are enriched on the male X chromosome. Polytene chromosomes from the male third instar larvae were immunostained with antibodies against MSL3 (<italic>green</italic>) and MSL2 (<italic>orange</italic>). DNA is visualized by Hoechst (<italic>blue</italic>). The figure illustrates that MSL proteins specifically recognize and colocalize on hundreds of sites on the male X chromosome</p></caption>
###xml 1629 1629 1629 1629 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="anchor" xlink:href="412_2006_89_Fig2_HTML" id="MO2"/>
###xml 1280 1629 1280 1629 <fig xmlns:xlink="http://www.w3.org/1999/xlink" id="Fig2"><label>Fig.&#160;2</label><caption><p textid="8">MSL proteins are enriched on the male X chromosome. Polytene chromosomes from the male third instar larvae were immunostained with antibodies against MSL3 (<italic>green</italic>) and MSL2 (<italic>orange</italic>). DNA is visualized by Hoechst (<italic>blue</italic>). The figure illustrates that MSL proteins specifically recognize and colocalize on hundreds of sites on the male X chromosome</p></caption><graphic position="anchor" xlink:href="412_2006_89_Fig2_HTML" id="MO2"/></fig>
The proteins encoded by the male specific lethal genes are collectively named MSLs and include MSL1, MSL2, MSL3, MLE (maleless), and MOF (males absent on the first). Immunofluorescence studies beautifully visualized these proteins colocalizing on hundreds of sites along the male X chromosome, suggesting that they might work together at specific chromosomal sites to promote dosage compensation (see Fig. 2) (Kuroda et al. 1991; Palmer et al. 1993). Indeed, biochemical characterization of MSLs confirmed that they interact physically and form an X-chromosome-specific MSL complex or the dosage compensation complex (DCC) (Copps et al. 1998; Meller et al. 2000; Mendjan et al. 2006; Scott et al. 2000; Smith et al. 2000). Moreover, two noncoding RNAs, roX1 and roX2 (RNA on the X), colocalize specifically with MSLs on the X (Amrein and Axel 1997; Meller et al. 1997). The roX1/roX2 double-mutant flies exhibit an MSL phenotype, and both RNAs were shown to interact with the MSL complex (Franke and Baker 1999; Meller and Rattner 2002; Meller et al. 1997; Smith et al. 2000). MSLs and roX RNAs assemble together at specific nucleation sites on the X chromosome, which have various affinities for the MSL complex (Dahlsveen et al. 2006; Demakova et al. 2003; Kelley et al. 1999). Fig. 2MSL proteins are enriched on the male X chromosome. Polytene chromosomes from the male third instar larvae were immunostained with antibodies against MSL3 (green) and MSL2 (orange). DNA is visualized by Hoechst (blue). The figure illustrates that MSL proteins specifically recognize and colocalize on hundreds of sites on the male X chromosome
###end p 7
###begin p 8
###xml 156 161 156 161 <italic xmlns:xlink="http://www.w3.org/1999/xlink">green</italic>
###xml 173 179 173 179 <italic xmlns:xlink="http://www.w3.org/1999/xlink">orange</italic>
###xml 212 216 212 216 <italic xmlns:xlink="http://www.w3.org/1999/xlink">blue</italic>
MSL proteins are enriched on the male X chromosome. Polytene chromosomes from the male third instar larvae were immunostained with antibodies against MSL3 (green) and MSL2 (orange). DNA is visualized by Hoechst (blue). The figure illustrates that MSL proteins specifically recognize and colocalize on hundreds of sites on the male X chromosome
###end p 8
###begin p 9
Thus, the MSL complex is a unique ribonucleoprotein complex that specifically recognizes the male X chromosome and mediates a twofold transcriptional upregulation of most X-linked genes irrespective of their inherent differences in expression levels.
###end p 9
###begin title 10
Lessons from MSLs-together they are strong
###end title 10
###begin p 11
###xml 863 864 863 864 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig3" ref-type="fig">3</xref>
###xml 872 873 872 873 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Tab1" ref-type="table">1</xref>
###xml 1141 1142 1141 1142 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Tab1" ref-type="table">1</xref>
###xml 1170 1174 1170 1174 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR36">2004</xref>
###xml 1191 1195 1191 1195 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR83">2006</xref>
###xml 1220 1224 1220 1224 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR100">2005</xref>
###xml 1460 1466 1460 1466 <label xmlns:xlink="http://www.w3.org/1999/xlink">Fig.&#160;3</label>
###xml 1466 1589 1466 1589 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="12">Domains in MSL complex members. Schematic representation of domain organization in MSL complex members (not drawn to scale)</p>
###xml 1466 1589 1466 1589 <caption xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="12">Domains in MSL complex members. Schematic representation of domain organization in MSL complex members (not drawn to scale)</p></caption>
###xml 1589 1589 1589 1589 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="anchor" xlink:href="412_2006_89_Fig3_HTML" id="MO3"/>
###xml 1460 1589 1460 1589 <fig xmlns:xlink="http://www.w3.org/1999/xlink" id="Fig3"><label>Fig.&#160;3</label><caption><p textid="12">Domains in MSL complex members. Schematic representation of domain organization in MSL complex members (not drawn to scale)</p></caption><graphic position="anchor" xlink:href="412_2006_89_Fig3_HTML" id="MO3"/></fig>
###xml 1589 1596 1589 1596 <label xmlns:xlink="http://www.w3.org/1999/xlink">Table&#160;1</label>
###xml 1596 1676 1596 1676 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="13">Summary of deletion mapping and interaction studies of MSL proteins and roX RNAs</p>
###xml 1596 1676 1596 1676 <caption xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="13">Summary of deletion mapping and interaction studies of MSL proteins and roX RNAs</p></caption>
###xml 1676 1712 1676 1712 <th xmlns:xlink="http://www.w3.org/1999/xlink">MSL complex members (domains/motifs)</th>
###xml 1712 1738 1712 1738 <th xmlns:xlink="http://www.w3.org/1999/xlink">Functions and interactions</th>
###xml 1738 1748 1738 1748 <th xmlns:xlink="http://www.w3.org/1999/xlink">References</th>
###xml 1676 1748 1676 1748 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><th>MSL complex members (domains/motifs)</th><th>Functions and interactions</th><th>References</th></tr>
###xml 1676 1748 1676 1748 <thead xmlns:xlink="http://www.w3.org/1999/xlink"><tr><th>MSL complex members (domains/motifs)</th><th>Functions and interactions</th><th>References</th></tr></thead>
###xml 1748 1815 1748 1815 <td xmlns:xlink="http://www.w3.org/1999/xlink" rowspan="6">MSL-1 (1039aa): basic motif, acidic region, coiled coil, PEHE motif</td>
###xml 1815 1887 1815 1887 <td xmlns:xlink="http://www.w3.org/1999/xlink">Protein region 85&#8211;186-aa required for interaction with MSL-2 RING finger</td>
###xml 1900 1904 1900 1904 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR23">1998</xref>
###xml 1887 1904 1887 1904 <td xmlns:xlink="http://www.w3.org/1999/xlink">Copps et al. <xref ref-type="bibr" rid="CR23">1998</xref></td>
###xml 1748 1904 1748 1904 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td rowspan="6">MSL-1 (1039aa): basic motif, acidic region, coiled coil, PEHE motif</td><td>Protein region 85&#8211;186-aa required for interaction with MSL-2 RING finger</td><td>Copps et al. <xref ref-type="bibr" rid="CR23">1998</xref></td></tr>
###xml 1904 1984 1904 1984 <td xmlns:xlink="http://www.w3.org/1999/xlink">N terminus of MSL-1 required for X-chromosome binding and MSL-1 self-association</td>
###xml 1994 1998 1994 1998 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR61">2005</xref>
###xml 1984 1998 1984 1998 <td xmlns:xlink="http://www.w3.org/1999/xlink">Li et al. <xref ref-type="bibr" rid="CR61">2005</xref></td>
###xml 1904 1998 1904 1998 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td>N terminus of MSL-1 required for X-chromosome binding and MSL-1 self-association</td><td>Li et al. <xref ref-type="bibr" rid="CR61">2005</xref></td></tr>
###xml 1998 2036 1998 2036 <td xmlns:xlink="http://www.w3.org/1999/xlink">C terminus interacts with MOF in vivo.</td>
###xml 2049 2053 2049 2053 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR87">2000</xref>
###xml 2036 2053 2036 2053 <td xmlns:xlink="http://www.w3.org/1999/xlink">Scott et al. <xref ref-type="bibr" rid="CR87">2000</xref></td>
###xml 1998 2053 1998 2053 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td>C terminus interacts with MOF in vivo.</td><td>Scott et al. <xref ref-type="bibr" rid="CR87">2000</xref></td></tr>
###xml 2053 2168 2053 2168 <td xmlns:xlink="http://www.w3.org/1999/xlink">A 84-aa N-terminal deletion that still interacts with MSL-2, fails to localize to the X, and causes male lethality.</td>
###xml 2181 2185 2181 2185 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR87">2000</xref>
###xml 2168 2185 2168 2185 <td xmlns:xlink="http://www.w3.org/1999/xlink">Scott et al. <xref ref-type="bibr" rid="CR87">2000</xref></td>
###xml 2053 2185 2053 2185 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td>A 84-aa N-terminal deletion that still interacts with MSL-2, fails to localize to the X, and causes male lethality.</td><td>Scott et al. <xref ref-type="bibr" rid="CR87">2000</xref></td></tr>
###xml 2185 2274 2185 2274 <td xmlns:xlink="http://www.w3.org/1999/xlink">MSL-1 is unstable in MSL-2 mutants, and it is stabilized in MSL-2 overexpressing females.</td>
###xml 2291 2295 2291 2295 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR20">1998</xref>
###xml 2274 2295 2274 2295 <td xmlns:xlink="http://www.w3.org/1999/xlink">Chang and Kuroda <xref ref-type="bibr" rid="CR20">1998</xref></td>
###xml 2185 2295 2185 2295 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td>MSL-1 is unstable in MSL-2 mutants, and it is stabilized in MSL-2 overexpressing females.</td><td>Chang and Kuroda <xref ref-type="bibr" rid="CR20">1998</xref></td></tr>
###xml 2295 2343 2295 2343 <td xmlns:xlink="http://www.w3.org/1999/xlink">PEHE motif essential for binding to MOF in vitro</td>
###xml 2358 2362 2358 2362 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR70">2004</xref>
###xml 2343 2362 2343 2362 <td xmlns:xlink="http://www.w3.org/1999/xlink">Morales et al. <xref ref-type="bibr" rid="CR70">2004</xref></td>
###xml 2295 2362 2295 2362 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td>PEHE motif essential for binding to MOF in vitro</td><td>Morales et al. <xref ref-type="bibr" rid="CR70">2004</xref></td></tr>
###xml 2362 2401 2362 2401 <td xmlns:xlink="http://www.w3.org/1999/xlink" rowspan="4">MSL-2 (773aa): RING finger, coiled coil</td>
###xml 2401 2473 2401 2473 <td xmlns:xlink="http://www.w3.org/1999/xlink">MSL-2 RING finger required for interaction with MSL-2 and male viability</td>
###xml 2486 2490 2486 2490 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR23">1998</xref>
###xml 2473 2490 2473 2490 <td xmlns:xlink="http://www.w3.org/1999/xlink">Copps et al. <xref ref-type="bibr" rid="CR23">1998</xref></td>
###xml 2362 2490 2362 2490 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td rowspan="4">MSL-2 (773aa): RING finger, coiled coil</td><td>MSL-2 RING finger required for interaction with MSL-2 and male viability</td><td>Copps et al. <xref ref-type="bibr" rid="CR23">1998</xref></td></tr>
###xml 2548 2553 2548 2553 <italic xmlns:xlink="http://www.w3.org/1999/xlink">msl-2</italic>
###xml 2490 2560 2490 2560 <td xmlns:xlink="http://www.w3.org/1999/xlink">Various critical RING finger point mutants fail to rescue <italic>msl-2</italic> flies.</td>
###xml 2573 2577 2573 2577 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR64">1997</xref>
###xml 2560 2577 2560 2577 <td xmlns:xlink="http://www.w3.org/1999/xlink">Lyman et al. <xref ref-type="bibr" rid="CR64">1997</xref></td>
###xml 2490 2577 2490 2577 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td>Various critical RING finger point mutants fail to rescue <italic>msl-2</italic> flies.</td><td>Lyman et al. <xref ref-type="bibr" rid="CR64">1997</xref></td></tr>
###xml 2577 2657 2577 2657 <td xmlns:xlink="http://www.w3.org/1999/xlink">Sex lethal binds 3&#8242; and 5&#8242; MSL-2 mRNA and inhibits MSL-2 translation in females.</td>
###xml 2674 2678 2674 2678 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR8">1997</xref>
###xml 2694 2698 2694 2698 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR53">1997</xref>
###xml 2715 2719 2715 2719 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR35">2003</xref>
###xml 2657 2719 2657 2719 <td xmlns:xlink="http://www.w3.org/1999/xlink">Bashaw and Baker <xref ref-type="bibr" rid="CR8">1997</xref>; Kelley et al. <xref ref-type="bibr" rid="CR53">1997</xref>; Gebauer et al. <xref ref-type="bibr" rid="CR35">2003</xref></td>
###xml 2577 2719 2577 2719 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td>Sex lethal binds 3&#8242; and 5&#8242; MSL-2 mRNA and inhibits MSL-2 translation in females.</td><td>Bashaw and Baker <xref ref-type="bibr" rid="CR8">1997</xref>; Kelley et al. <xref ref-type="bibr" rid="CR53">1997</xref>; Gebauer et al. <xref ref-type="bibr" rid="CR35">2003</xref></td></tr>
###xml 2719 2806 2719 2806 <td xmlns:xlink="http://www.w3.org/1999/xlink">Ectopic MSL-2 expression causes lethality in females that is dependent on MSL-1 levels.</td>
###xml 2820 2824 2820 2824 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR52">1995</xref>
###xml 2806 2824 2806 2824 <td xmlns:xlink="http://www.w3.org/1999/xlink">Kelley et al. <xref ref-type="bibr" rid="CR52">1995</xref></td>
###xml 2719 2824 2719 2824 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td>Ectopic MSL-2 expression causes lethality in females that is dependent on MSL-1 levels.</td><td>Kelley et al. <xref ref-type="bibr" rid="CR52">1995</xref></td></tr>
###xml 2824 2871 2824 2871 <td xmlns:xlink="http://www.w3.org/1999/xlink" rowspan="7">MSL-3 (512aa): chromo-barrel domain, MRG domain</td>
###xml 2871 2911 2871 2911 <td xmlns:xlink="http://www.w3.org/1999/xlink">Chromo-barrel domain binds RNA in vitro.</td>
###xml 2925 2929 2925 2929 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR4">2000</xref>
###xml 2911 2929 2911 2929 <td xmlns:xlink="http://www.w3.org/1999/xlink">Akhtar et al. <xref ref-type="bibr" rid="CR4">2000</xref></td>
###xml 2824 2929 2824 2929 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td rowspan="7">MSL-3 (512aa): chromo-barrel domain, MRG domain</td><td>Chromo-barrel domain binds RNA in vitro.</td><td>Akhtar et al. <xref ref-type="bibr" rid="CR4">2000</xref></td></tr>
###xml 2929 3015 2929 3015 <td xmlns:xlink="http://www.w3.org/1999/xlink">Chromo-barrel domain is required for dosage compensation but for targeting of the DCC.</td>
###xml 3031 3035 3031 3035 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR15">2006</xref>
###xml 3052 3056 3052 3056 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR71">2005</xref>
###xml 3015 3056 3015 3056 <td xmlns:xlink="http://www.w3.org/1999/xlink">Buscaino et al. <xref ref-type="bibr" rid="CR15">2006</xref>; Morales et al. <xref ref-type="bibr" rid="CR71">2005</xref></td>
###xml 2929 3056 2929 3056 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td>Chromo-barrel domain is required for dosage compensation but for targeting of the DCC.</td><td>Buscaino et al. <xref ref-type="bibr" rid="CR15">2006</xref>; Morales et al. <xref ref-type="bibr" rid="CR71">2005</xref></td></tr>
###xml 3056 3106 3056 3106 <td xmlns:xlink="http://www.w3.org/1999/xlink">MSL-3 associates with roX2 RNA in Schneider cells.</td>
###xml 3122 3126 3122 3126 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR14">2003</xref>
###xml 3106 3126 3106 3126 <td xmlns:xlink="http://www.w3.org/1999/xlink">Buscaino et al. <xref ref-type="bibr" rid="CR14">2003</xref></td>
###xml 3056 3126 3056 3126 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td>MSL-3 associates with roX2 RNA in Schneider cells.</td><td>Buscaino et al. <xref ref-type="bibr" rid="CR14">2003</xref></td></tr>
###xml 3126 3174 3126 3174 <td xmlns:xlink="http://www.w3.org/1999/xlink">MSL-3 is acetylated by MOF in vitro and in vivo.</td>
###xml 3190 3194 3190 3194 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR14">2003</xref>
###xml 3174 3194 3174 3194 <td xmlns:xlink="http://www.w3.org/1999/xlink">Buscaino et al. <xref ref-type="bibr" rid="CR14">2003</xref></td>
###xml 3126 3194 3126 3194 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td>MSL-3 is acetylated by MOF in vitro and in vivo.</td><td>Buscaino et al. <xref ref-type="bibr" rid="CR14">2003</xref></td></tr>
###xml 3194 3249 3194 3249 <td xmlns:xlink="http://www.w3.org/1999/xlink">DCC binds only to high-affinity sites in MSL-3 mutants.</td>
###xml 3262 3266 3262 3266 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR64">1997</xref>
###xml 3249 3266 3249 3266 <td xmlns:xlink="http://www.w3.org/1999/xlink">Lyman et al. <xref ref-type="bibr" rid="CR64">1997</xref></td>
###xml 3194 3266 3194 3266 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td>DCC binds only to high-affinity sites in MSL-3 mutants.</td><td>Lyman et al. <xref ref-type="bibr" rid="CR64">1997</xref></td></tr>
###xml 3266 3320 3266 3320 <td xmlns:xlink="http://www.w3.org/1999/xlink">MRG domain is required for DCC targeting and assembly.</td>
###xml 3336 3340 3336 3340 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR15">2006</xref>
###xml 3357 3361 3357 3361 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR71">2005</xref>
###xml 3320 3361 3320 3361 <td xmlns:xlink="http://www.w3.org/1999/xlink">Buscaino et al. <xref ref-type="bibr" rid="CR15">2006</xref>; Morales et al. <xref ref-type="bibr" rid="CR71">2005</xref></td>
###xml 3266 3361 3266 3361 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td>MRG domain is required for DCC targeting and assembly.</td><td>Buscaino et al. <xref ref-type="bibr" rid="CR15">2006</xref>; Morales et al. <xref ref-type="bibr" rid="CR71">2005</xref></td></tr>
###xml 3361 3427 3361 3427 <td xmlns:xlink="http://www.w3.org/1999/xlink">MSL-3 interacts directly with MOF and stimulates its HAT activity.</td>
###xml 3442 3446 3442 3446 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR70">2004</xref>
###xml 3427 3446 3427 3446 <td xmlns:xlink="http://www.w3.org/1999/xlink">Morales et al. <xref ref-type="bibr" rid="CR70">2004</xref></td>
###xml 3361 3446 3361 3446 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td>MSL-3 interacts directly with MOF and stimulates its HAT activity.</td><td>Morales et al. <xref ref-type="bibr" rid="CR70">2004</xref></td></tr>
###xml 3446 3504 3446 3504 <td xmlns:xlink="http://www.w3.org/1999/xlink" rowspan="6">MOF (827aa): chromo-barrel domain, zinc finger, HAT domain</td>
###xml 3504 3559 3504 3559 <td xmlns:xlink="http://www.w3.org/1999/xlink">HAT domain point mutant causes male-specific lethality.</td>
###xml 3575 3579 3575 3579 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR46">1997</xref>
###xml 3559 3579 3559 3579 <td xmlns:xlink="http://www.w3.org/1999/xlink">Hilfiker et al. <xref ref-type="bibr" rid="CR46">1997</xref></td>
###xml 3446 3579 3446 3579 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td rowspan="6">MOF (827aa): chromo-barrel domain, zinc finger, HAT domain</td><td>HAT domain point mutant causes male-specific lethality.</td><td>Hilfiker et al. <xref ref-type="bibr" rid="CR46">1997</xref></td></tr>
###xml 3579 3634 3579 3634 <td xmlns:xlink="http://www.w3.org/1999/xlink">HAT domain required for specific acetylation of H4k16Ac</td>
###xml 3647 3651 3647 3651 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR90">2000</xref>
###xml 3671 3675 3671 3675 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR3">2001</xref>
###xml 3634 3675 3634 3675 <td xmlns:xlink="http://www.w3.org/1999/xlink">Smith et al. <xref ref-type="bibr" rid="CR90">2000</xref>; Akhtar and Becker <xref ref-type="bibr" rid="CR3">2001</xref></td>
###xml 3579 3675 3579 3675 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td>HAT domain required for specific acetylation of H4k16Ac</td><td>Smith et al. <xref ref-type="bibr" rid="CR90">2000</xref>; Akhtar and Becker <xref ref-type="bibr" rid="CR3">2001</xref></td></tr>
###xml 3675 3738 3675 3738 <td xmlns:xlink="http://www.w3.org/1999/xlink">Only enzymatically active MOF activates transcription in vitro.</td>
###xml 3756 3760 3756 3760 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR2">2000</xref>
###xml 3738 3760 3738 3760 <td xmlns:xlink="http://www.w3.org/1999/xlink">Akhtar and Becker <xref ref-type="bibr" rid="CR2">2000</xref></td>
###xml 3675 3760 3675 3760 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td>Only enzymatically active MOF activates transcription in vitro.</td><td>Akhtar and Becker <xref ref-type="bibr" rid="CR2">2000</xref></td></tr>
###xml 3760 3800 3760 3800 <td xmlns:xlink="http://www.w3.org/1999/xlink">Chromo-barrel domain binds RNA in vitro.</td>
###xml 3814 3818 3814 3818 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR4">2000</xref>
###xml 3835 3839 3835 3839 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR75">2005</xref>
###xml 3800 3839 3800 3839 <td xmlns:xlink="http://www.w3.org/1999/xlink">Akhtar et al. <xref ref-type="bibr" rid="CR4">2000</xref>; Nielsen et al. <xref ref-type="bibr" rid="CR75">2005</xref></td>
###xml 3760 3839 3760 3839 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td>Chromo-barrel domain binds RNA in vitro.</td><td>Akhtar et al. <xref ref-type="bibr" rid="CR4">2000</xref>; Nielsen et al. <xref ref-type="bibr" rid="CR75">2005</xref></td></tr>
###xml 3839 3896 3839 3896 <td xmlns:xlink="http://www.w3.org/1999/xlink">C2HC zinc finger required for nucleosome binding in vitro</td>
###xml 3914 3918 3914 3918 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR3">2001</xref>
###xml 3896 3918 3896 3918 <td xmlns:xlink="http://www.w3.org/1999/xlink">Akhtar and Becker <xref ref-type="bibr" rid="CR3">2001</xref></td>
###xml 3839 3918 3839 3918 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td>C2HC zinc finger required for nucleosome binding in vitro</td><td>Akhtar and Becker <xref ref-type="bibr" rid="CR3">2001</xref></td></tr>
###xml 3918 3970 3918 3970 <td xmlns:xlink="http://www.w3.org/1999/xlink">MOF associates with roX2 in vivo in Schneider cells.</td>
###xml 3984 3988 3984 3988 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR4">2000</xref>
###xml 4005 4009 4005 4009 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR68">2006</xref>
###xml 3970 4009 3970 4009 <td xmlns:xlink="http://www.w3.org/1999/xlink">Akhtar et al. <xref ref-type="bibr" rid="CR4">2000</xref>; Mendjan et al. <xref ref-type="bibr" rid="CR68">2006</xref></td>
###xml 3918 4009 3918 4009 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td>MOF associates with roX2 in vivo in Schneider cells.</td><td>Akhtar et al. <xref ref-type="bibr" rid="CR4">2000</xref>; Mendjan et al. <xref ref-type="bibr" rid="CR68">2006</xref></td></tr>
###xml 4009 4060 4009 4060 <td xmlns:xlink="http://www.w3.org/1999/xlink" rowspan="7">MLE (1293aa): dsRNA-binding domain, helicase domain</td>
###xml 4060 4121 4060 4121 <td xmlns:xlink="http://www.w3.org/1999/xlink">Helicase activity on RNA: RNA, RNA: DNA, and DNA: DNA hybrids</td>
###xml 4132 4136 4132 4136 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR58">1997</xref>
###xml 4121 4136 4121 4136 <td xmlns:xlink="http://www.w3.org/1999/xlink">Lee et al. <xref ref-type="bibr" rid="CR58">1997</xref></td>
###xml 4009 4136 4009 4136 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td rowspan="7">MLE (1293aa): dsRNA-binding domain, helicase domain</td><td>Helicase activity on RNA: RNA, RNA: DNA, and DNA: DNA hybrids</td><td>Lee et al. <xref ref-type="bibr" rid="CR58">1997</xref></td></tr>
###xml 4136 4193 4136 4193 <td xmlns:xlink="http://www.w3.org/1999/xlink">ATPase activity and DExD box important for male viability</td>
###xml 4208 4212 4208 4212 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR85">1996</xref>
###xml 4193 4212 4193 4212 <td xmlns:xlink="http://www.w3.org/1999/xlink">Richter et al. <xref ref-type="bibr" rid="CR85">1996</xref></td>
###xml 4136 4212 4136 4212 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td>ATPase activity and DExD box important for male viability</td><td>Richter et al. <xref ref-type="bibr" rid="CR85">1996</xref></td></tr>
###xml 4212 4270 4212 4270 <td xmlns:xlink="http://www.w3.org/1999/xlink">ATPase activity required for complex spreading along the X</td>
###xml 4281 4285 4281 4285 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR58">1997</xref>
###xml 4297 4301 4297 4301 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR41">2000</xref>
###xml 4270 4301 4270 4301 <td xmlns:xlink="http://www.w3.org/1999/xlink">Lee et al. <xref ref-type="bibr" rid="CR58">1997</xref>; Gu et al. <xref ref-type="bibr" rid="CR41">2000</xref></td>
###xml 4212 4301 4212 4301 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td>ATPase activity required for complex spreading along the X</td><td>Lee et al. <xref ref-type="bibr" rid="CR58">1997</xref>; Gu et al. <xref ref-type="bibr" rid="CR41">2000</xref></td></tr>
###xml 4301 4350 4301 4350 <td xmlns:xlink="http://www.w3.org/1999/xlink">Helicase activity essential for roX RNA stability</td>
###xml 4360 4364 4360 4364 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR41">2000</xref>
###xml 4350 4364 4350 4364 <td xmlns:xlink="http://www.w3.org/1999/xlink">Gu et al. <xref ref-type="bibr" rid="CR41">2000</xref></td>
###xml 4301 4364 4301 4364 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td>Helicase activity essential for roX RNA stability</td><td>Gu et al. <xref ref-type="bibr" rid="CR41">2000</xref></td></tr>
###xml 4364 4397 4364 4397 <td xmlns:xlink="http://www.w3.org/1999/xlink">roX2 associates with MLE in vivo.</td>
###xml 4411 4415 4411 4415 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR67">2000</xref>
###xml 4397 4415 4397 4415 <td xmlns:xlink="http://www.w3.org/1999/xlink">Meller et al. <xref ref-type="bibr" rid="CR67">2000</xref></td>
###xml 4364 4415 4364 4415 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td>roX2 associates with MLE in vivo.</td><td>Meller et al. <xref ref-type="bibr" rid="CR67">2000</xref></td></tr>
###xml 4415 4502 4415 4502 <td xmlns:xlink="http://www.w3.org/1999/xlink">The C terminus (941&#8211;1293-aa) can associate with chromatin in an RNAse-sensitive manner.</td>
###xml 4517 4521 4517 4521 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR85">1996</xref>
###xml 4502 4521 4502 4521 <td xmlns:xlink="http://www.w3.org/1999/xlink">Richter et al. <xref ref-type="bibr" rid="CR85">1996</xref></td>
###xml 4415 4521 4415 4521 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td>The C terminus (941&#8211;1293-aa) can associate with chromatin in an RNAse-sensitive manner.</td><td>Richter et al. <xref ref-type="bibr" rid="CR85">1996</xref></td></tr>
###xml 4542 4545 4542 4545 <italic xmlns:xlink="http://www.w3.org/1999/xlink">nap</italic>
###xml 4593 4597 4593 4597 <italic xmlns:xlink="http://www.w3.org/1999/xlink">para</italic>
###xml 4521 4597 4521 4597 <td xmlns:xlink="http://www.w3.org/1999/xlink">No action potential (<italic>nap</italic>) allele of MLE required for mRNA processing of <italic>para</italic></td>
###xml 4611 4615 4611 4615 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR84">2000</xref>
###xml 4597 4615 4597 4615 <td xmlns:xlink="http://www.w3.org/1999/xlink">Reenan et al. <xref ref-type="bibr" rid="CR84">2000</xref></td>
###xml 4521 4615 4521 4615 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td>No action potential (<italic>nap</italic>) allele of MLE required for mRNA processing of <italic>para</italic></td><td>Reenan et al. <xref ref-type="bibr" rid="CR84">2000</xref></td></tr>
###xml 4615 4656 4615 4656 <td xmlns:xlink="http://www.w3.org/1999/xlink" rowspan="5">roX1/roX2 (3.7&#160;kb/0.6&#160;kb): roX1 stem loop</td>
###xml 4656 4727 4656 4727 <td xmlns:xlink="http://www.w3.org/1999/xlink">In roX1/roX2 double mutants, the DCC is not properly targeted to the X.</td>
###xml 4746 4750 4746 4750 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR65">2002</xref>
###xml 4727 4750 4727 4750 <td xmlns:xlink="http://www.w3.org/1999/xlink">Meller and Rattner <xref ref-type="bibr" rid="CR65">2002</xref></td>
###xml 4615 4750 4615 4750 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td rowspan="5">roX1/roX2 (3.7&#160;kb/0.6&#160;kb): roX1 stem loop</td><td>In roX1/roX2 double mutants, the DCC is not properly targeted to the X.</td><td>Meller and Rattner <xref ref-type="bibr" rid="CR65">2002</xref></td></tr>
###xml 4750 4829 4750 4829 <td xmlns:xlink="http://www.w3.org/1999/xlink">MSL-1 and MSL-2 overexpression partially rescues male lethality in roX mutants.</td>
###xml 4839 4843 4839 4843 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR76">2003</xref>
###xml 4829 4843 4829 4843 <td xmlns:xlink="http://www.w3.org/1999/xlink">Oh et al. <xref ref-type="bibr" rid="CR76">2003</xref></td>
###xml 4750 4843 4750 4843 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td>MSL-1 and MSL-2 overexpression partially rescues male lethality in roX mutants.</td><td>Oh et al. <xref ref-type="bibr" rid="CR76">2003</xref></td></tr>
###xml 4843 4888 4843 4888 <td xmlns:xlink="http://www.w3.org/1999/xlink">Stem loop in roX1 important for roX1 function</td>
###xml 4907 4911 4907 4911 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR97">2003</xref>
###xml 4888 4911 4888 4911 <td xmlns:xlink="http://www.w3.org/1999/xlink">Stuckenholz et al. <xref ref-type="bibr" rid="CR97">2003</xref></td>
###xml 4843 4911 4843 4911 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td>Stem loop in roX1 important for roX1 function</td><td>Stuckenholz et al. <xref ref-type="bibr" rid="CR97">2003</xref></td></tr>
###xml 4911 4978 4911 4978 <td xmlns:xlink="http://www.w3.org/1999/xlink">roX2 variable splicing influences DCC assembly on the X chromosome.</td>
###xml 4990 4994 4990 4994 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR81">2005</xref>
###xml 4978 4994 4978 4994 <td xmlns:xlink="http://www.w3.org/1999/xlink">Park et al. <xref ref-type="bibr" rid="CR81">2005</xref></td>
###xml 4911 4994 4911 4994 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td>roX2 variable splicing influences DCC assembly on the X chromosome.</td><td>Park et al. <xref ref-type="bibr" rid="CR81">2005</xref></td></tr>
###xml 4994 5056 4994 5056 <td xmlns:xlink="http://www.w3.org/1999/xlink">Approximately 10% deletions of roX1 do not affect roX function</td>
###xml 5075 5079 5075 5079 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR97">2003</xref>
###xml 5056 5079 5056 5079 <td xmlns:xlink="http://www.w3.org/1999/xlink">Stuckenholz et al. <xref ref-type="bibr" rid="CR97">2003</xref></td>
###xml 4994 5079 4994 5079 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td>Approximately 10% deletions of roX1 do not affect roX function</td><td>Stuckenholz et al. <xref ref-type="bibr" rid="CR97">2003</xref></td></tr>
###xml 1748 5079 1748 5079 <tbody xmlns:xlink="http://www.w3.org/1999/xlink"><tr><td rowspan="6">MSL-1 (1039aa): basic motif, acidic region, coiled coil, PEHE motif</td><td>Protein region 85&#8211;186-aa required for interaction with MSL-2 RING finger</td><td>Copps et al. <xref ref-type="bibr" rid="CR23">1998</xref></td></tr><tr><td>N terminus of MSL-1 required for X-chromosome binding and MSL-1 self-association</td><td>Li et al. <xref ref-type="bibr" rid="CR61">2005</xref></td></tr><tr><td>C terminus interacts with MOF in vivo.</td><td>Scott et al. <xref ref-type="bibr" rid="CR87">2000</xref></td></tr><tr><td>A 84-aa N-terminal deletion that still interacts with MSL-2, fails to localize to the X, and causes male lethality.</td><td>Scott et al. <xref ref-type="bibr" rid="CR87">2000</xref></td></tr><tr><td>MSL-1 is unstable in MSL-2 mutants, and it is stabilized in MSL-2 overexpressing females.</td><td>Chang and Kuroda <xref ref-type="bibr" rid="CR20">1998</xref></td></tr><tr><td>PEHE motif essential for binding to MOF in vitro</td><td>Morales et al. <xref ref-type="bibr" rid="CR70">2004</xref></td></tr><tr><td rowspan="4">MSL-2 (773aa): RING finger, coiled coil</td><td>MSL-2 RING finger required for interaction with MSL-2 and male viability</td><td>Copps et al. <xref ref-type="bibr" rid="CR23">1998</xref></td></tr><tr><td>Various critical RING finger point mutants fail to rescue <italic>msl-2</italic> flies.</td><td>Lyman et al. <xref ref-type="bibr" rid="CR64">1997</xref></td></tr><tr><td>Sex lethal binds 3&#8242; and 5&#8242; MSL-2 mRNA and inhibits MSL-2 translation in females.</td><td>Bashaw and Baker <xref ref-type="bibr" rid="CR8">1997</xref>; Kelley et al. <xref ref-type="bibr" rid="CR53">1997</xref>; Gebauer et al. <xref ref-type="bibr" rid="CR35">2003</xref></td></tr><tr><td>Ectopic MSL-2 expression causes lethality in females that is dependent on MSL-1 levels.</td><td>Kelley et al. <xref ref-type="bibr" rid="CR52">1995</xref></td></tr><tr><td rowspan="7">MSL-3 (512aa): chromo-barrel domain, MRG domain</td><td>Chromo-barrel domain binds RNA in vitro.</td><td>Akhtar et al. <xref ref-type="bibr" rid="CR4">2000</xref></td></tr><tr><td>Chromo-barrel domain is required for dosage compensation but for targeting of the DCC.</td><td>Buscaino et al. <xref ref-type="bibr" rid="CR15">2006</xref>; Morales et al. <xref ref-type="bibr" rid="CR71">2005</xref></td></tr><tr><td>MSL-3 associates with roX2 RNA in Schneider cells.</td><td>Buscaino et al. <xref ref-type="bibr" rid="CR14">2003</xref></td></tr><tr><td>MSL-3 is acetylated by MOF in vitro and in vivo.</td><td>Buscaino et al. <xref ref-type="bibr" rid="CR14">2003</xref></td></tr><tr><td>DCC binds only to high-affinity sites in MSL-3 mutants.</td><td>Lyman et al. <xref ref-type="bibr" rid="CR64">1997</xref></td></tr><tr><td>MRG domain is required for DCC targeting and assembly.</td><td>Buscaino et al. <xref ref-type="bibr" rid="CR15">2006</xref>; Morales et al. <xref ref-type="bibr" rid="CR71">2005</xref></td></tr><tr><td>MSL-3 interacts directly with MOF and stimulates its HAT activity.</td><td>Morales et al. <xref ref-type="bibr" rid="CR70">2004</xref></td></tr><tr><td rowspan="6">MOF (827aa): chromo-barrel domain, zinc finger, HAT domain</td><td>HAT domain point mutant causes male-specific lethality.</td><td>Hilfiker et al. <xref ref-type="bibr" rid="CR46">1997</xref></td></tr><tr><td>HAT domain required for specific acetylation of H4k16Ac</td><td>Smith et al. <xref ref-type="bibr" rid="CR90">2000</xref>; Akhtar and Becker <xref ref-type="bibr" rid="CR3">2001</xref></td></tr><tr><td>Only enzymatically active MOF activates transcription in vitro.</td><td>Akhtar and Becker <xref ref-type="bibr" rid="CR2">2000</xref></td></tr><tr><td>Chromo-barrel domain binds RNA in vitro.</td><td>Akhtar et al. <xref ref-type="bibr" rid="CR4">2000</xref>; Nielsen et al. <xref ref-type="bibr" rid="CR75">2005</xref></td></tr><tr><td>C2HC zinc finger required for nucleosome binding in vitro</td><td>Akhtar and Becker <xref ref-type="bibr" rid="CR3">2001</xref></td></tr><tr><td>MOF associates with roX2 in vivo in Schneider cells.</td><td>Akhtar et al. <xref ref-type="bibr" rid="CR4">2000</xref>; Mendjan et al. <xref ref-type="bibr" rid="CR68">2006</xref></td></tr><tr><td rowspan="7">MLE (1293aa): dsRNA-binding domain, helicase domain</td><td>Helicase activity on RNA: RNA, RNA: DNA, and DNA: DNA hybrids</td><td>Lee et al. <xref ref-type="bibr" rid="CR58">1997</xref></td></tr><tr><td>ATPase activity and DExD box important for male viability</td><td>Richter et al. <xref ref-type="bibr" rid="CR85">1996</xref></td></tr><tr><td>ATPase activity required for complex spreading along the X</td><td>Lee et al. <xref ref-type="bibr" rid="CR58">1997</xref>; Gu et al. <xref ref-type="bibr" rid="CR41">2000</xref></td></tr><tr><td>Helicase activity essential for roX RNA stability</td><td>Gu et al. <xref ref-type="bibr" rid="CR41">2000</xref></td></tr><tr><td>roX2 associates with MLE in vivo.</td><td>Meller et al. <xref ref-type="bibr" rid="CR67">2000</xref></td></tr><tr><td>The C terminus (941&#8211;1293-aa) can associate with chromatin in an RNAse-sensitive manner.</td><td>Richter et al. <xref ref-type="bibr" rid="CR85">1996</xref></td></tr><tr><td>No action potential (<italic>nap</italic>) allele of MLE required for mRNA processing of <italic>para</italic></td><td>Reenan et al. <xref ref-type="bibr" rid="CR84">2000</xref></td></tr><tr><td rowspan="5">roX1/roX2 (3.7&#160;kb/0.6&#160;kb): roX1 stem loop</td><td>In roX1/roX2 double mutants, the DCC is not properly targeted to the X.</td><td>Meller and Rattner <xref ref-type="bibr" rid="CR65">2002</xref></td></tr><tr><td>MSL-1 and MSL-2 overexpression partially rescues male lethality in roX mutants.</td><td>Oh et al. <xref ref-type="bibr" rid="CR76">2003</xref></td></tr><tr><td>Stem loop in roX1 important for roX1 function</td><td>Stuckenholz et al. <xref ref-type="bibr" rid="CR97">2003</xref></td></tr><tr><td>roX2 variable splicing influences DCC assembly on the X chromosome.</td><td>Park et al. <xref ref-type="bibr" rid="CR81">2005</xref></td></tr><tr><td>Approximately 10% deletions of roX1 do not affect roX function</td><td>Stuckenholz et al. <xref ref-type="bibr" rid="CR97">2003</xref></td></tr></tbody>
###xml 1676 5079 1676 5079 <table xmlns:xlink="http://www.w3.org/1999/xlink" frame="hsides" rules="groups"><thead><tr><th>MSL complex members (domains/motifs)</th><th>Functions and interactions</th><th>References</th></tr></thead><tbody><tr><td rowspan="6">MSL-1 (1039aa): basic motif, acidic region, coiled coil, PEHE motif</td><td>Protein region 85&#8211;186-aa required for interaction with MSL-2 RING finger</td><td>Copps et al. <xref ref-type="bibr" rid="CR23">1998</xref></td></tr><tr><td>N terminus of MSL-1 required for X-chromosome binding and MSL-1 self-association</td><td>Li et al. <xref ref-type="bibr" rid="CR61">2005</xref></td></tr><tr><td>C terminus interacts with MOF in vivo.</td><td>Scott et al. <xref ref-type="bibr" rid="CR87">2000</xref></td></tr><tr><td>A 84-aa N-terminal deletion that still interacts with MSL-2, fails to localize to the X, and causes male lethality.</td><td>Scott et al. <xref ref-type="bibr" rid="CR87">2000</xref></td></tr><tr><td>MSL-1 is unstable in MSL-2 mutants, and it is stabilized in MSL-2 overexpressing females.</td><td>Chang and Kuroda <xref ref-type="bibr" rid="CR20">1998</xref></td></tr><tr><td>PEHE motif essential for binding to MOF in vitro</td><td>Morales et al. <xref ref-type="bibr" rid="CR70">2004</xref></td></tr><tr><td rowspan="4">MSL-2 (773aa): RING finger, coiled coil</td><td>MSL-2 RING finger required for interaction with MSL-2 and male viability</td><td>Copps et al. <xref ref-type="bibr" rid="CR23">1998</xref></td></tr><tr><td>Various critical RING finger point mutants fail to rescue <italic>msl-2</italic> flies.</td><td>Lyman et al. <xref ref-type="bibr" rid="CR64">1997</xref></td></tr><tr><td>Sex lethal binds 3&#8242; and 5&#8242; MSL-2 mRNA and inhibits MSL-2 translation in females.</td><td>Bashaw and Baker <xref ref-type="bibr" rid="CR8">1997</xref>; Kelley et al. <xref ref-type="bibr" rid="CR53">1997</xref>; Gebauer et al. <xref ref-type="bibr" rid="CR35">2003</xref></td></tr><tr><td>Ectopic MSL-2 expression causes lethality in females that is dependent on MSL-1 levels.</td><td>Kelley et al. <xref ref-type="bibr" rid="CR52">1995</xref></td></tr><tr><td rowspan="7">MSL-3 (512aa): chromo-barrel domain, MRG domain</td><td>Chromo-barrel domain binds RNA in vitro.</td><td>Akhtar et al. <xref ref-type="bibr" rid="CR4">2000</xref></td></tr><tr><td>Chromo-barrel domain is required for dosage compensation but for targeting of the DCC.</td><td>Buscaino et al. <xref ref-type="bibr" rid="CR15">2006</xref>; Morales et al. <xref ref-type="bibr" rid="CR71">2005</xref></td></tr><tr><td>MSL-3 associates with roX2 RNA in Schneider cells.</td><td>Buscaino et al. <xref ref-type="bibr" rid="CR14">2003</xref></td></tr><tr><td>MSL-3 is acetylated by MOF in vitro and in vivo.</td><td>Buscaino et al. <xref ref-type="bibr" rid="CR14">2003</xref></td></tr><tr><td>DCC binds only to high-affinity sites in MSL-3 mutants.</td><td>Lyman et al. <xref ref-type="bibr" rid="CR64">1997</xref></td></tr><tr><td>MRG domain is required for DCC targeting and assembly.</td><td>Buscaino et al. <xref ref-type="bibr" rid="CR15">2006</xref>; Morales et al. <xref ref-type="bibr" rid="CR71">2005</xref></td></tr><tr><td>MSL-3 interacts directly with MOF and stimulates its HAT activity.</td><td>Morales et al. <xref ref-type="bibr" rid="CR70">2004</xref></td></tr><tr><td rowspan="6">MOF (827aa): chromo-barrel domain, zinc finger, HAT domain</td><td>HAT domain point mutant causes male-specific lethality.</td><td>Hilfiker et al. <xref ref-type="bibr" rid="CR46">1997</xref></td></tr><tr><td>HAT domain required for specific acetylation of H4k16Ac</td><td>Smith et al. <xref ref-type="bibr" rid="CR90">2000</xref>; Akhtar and Becker <xref ref-type="bibr" rid="CR3">2001</xref></td></tr><tr><td>Only enzymatically active MOF activates transcription in vitro.</td><td>Akhtar and Becker <xref ref-type="bibr" rid="CR2">2000</xref></td></tr><tr><td>Chromo-barrel domain binds RNA in vitro.</td><td>Akhtar et al. <xref ref-type="bibr" rid="CR4">2000</xref>; Nielsen et al. <xref ref-type="bibr" rid="CR75">2005</xref></td></tr><tr><td>C2HC zinc finger required for nucleosome binding in vitro</td><td>Akhtar and Becker <xref ref-type="bibr" rid="CR3">2001</xref></td></tr><tr><td>MOF associates with roX2 in vivo in Schneider cells.</td><td>Akhtar et al. <xref ref-type="bibr" rid="CR4">2000</xref>; Mendjan et al. <xref ref-type="bibr" rid="CR68">2006</xref></td></tr><tr><td rowspan="7">MLE (1293aa): dsRNA-binding domain, helicase domain</td><td>Helicase activity on RNA: RNA, RNA: DNA, and DNA: DNA hybrids</td><td>Lee et al. <xref ref-type="bibr" rid="CR58">1997</xref></td></tr><tr><td>ATPase activity and DExD box important for male viability</td><td>Richter et al. <xref ref-type="bibr" rid="CR85">1996</xref></td></tr><tr><td>ATPase activity required for complex spreading along the X</td><td>Lee et al. <xref ref-type="bibr" rid="CR58">1997</xref>; Gu et al. <xref ref-type="bibr" rid="CR41">2000</xref></td></tr><tr><td>Helicase activity essential for roX RNA stability</td><td>Gu et al. <xref ref-type="bibr" rid="CR41">2000</xref></td></tr><tr><td>roX2 associates with MLE in vivo.</td><td>Meller et al. <xref ref-type="bibr" rid="CR67">2000</xref></td></tr><tr><td>The C terminus (941&#8211;1293-aa) can associate with chromatin in an RNAse-sensitive manner.</td><td>Richter et al. <xref ref-type="bibr" rid="CR85">1996</xref></td></tr><tr><td>No action potential (<italic>nap</italic>) allele of MLE required for mRNA processing of <italic>para</italic></td><td>Reenan et al. <xref ref-type="bibr" rid="CR84">2000</xref></td></tr><tr><td rowspan="5">roX1/roX2 (3.7&#160;kb/0.6&#160;kb): roX1 stem loop</td><td>In roX1/roX2 double mutants, the DCC is not properly targeted to the X.</td><td>Meller and Rattner <xref ref-type="bibr" rid="CR65">2002</xref></td></tr><tr><td>MSL-1 and MSL-2 overexpression partially rescues male lethality in roX mutants.</td><td>Oh et al. <xref ref-type="bibr" rid="CR76">2003</xref></td></tr><tr><td>Stem loop in roX1 important for roX1 function</td><td>Stuckenholz et al. <xref ref-type="bibr" rid="CR97">2003</xref></td></tr><tr><td>roX2 variable splicing influences DCC assembly on the X chromosome.</td><td>Park et al. <xref ref-type="bibr" rid="CR81">2005</xref></td></tr><tr><td>Approximately 10% deletions of roX1 do not affect roX function</td><td>Stuckenholz et al. <xref ref-type="bibr" rid="CR97">2003</xref></td></tr></tbody></table>
###xml 1589 5079 1589 5079 <table-wrap xmlns:xlink="http://www.w3.org/1999/xlink" id="Tab1"><label>Table&#160;1</label><caption><p textid="13">Summary of deletion mapping and interaction studies of MSL proteins and roX RNAs</p></caption><table frame="hsides" rules="groups"><thead><tr><th>MSL complex members (domains/motifs)</th><th>Functions and interactions</th><th>References</th></tr></thead><tbody><tr><td rowspan="6">MSL-1 (1039aa): basic motif, acidic region, coiled coil, PEHE motif</td><td>Protein region 85&#8211;186-aa required for interaction with MSL-2 RING finger</td><td>Copps et al. <xref ref-type="bibr" rid="CR23">1998</xref></td></tr><tr><td>N terminus of MSL-1 required for X-chromosome binding and MSL-1 self-association</td><td>Li et al. <xref ref-type="bibr" rid="CR61">2005</xref></td></tr><tr><td>C terminus interacts with MOF in vivo.</td><td>Scott et al. <xref ref-type="bibr" rid="CR87">2000</xref></td></tr><tr><td>A 84-aa N-terminal deletion that still interacts with MSL-2, fails to localize to the X, and causes male lethality.</td><td>Scott et al. <xref ref-type="bibr" rid="CR87">2000</xref></td></tr><tr><td>MSL-1 is unstable in MSL-2 mutants, and it is stabilized in MSL-2 overexpressing females.</td><td>Chang and Kuroda <xref ref-type="bibr" rid="CR20">1998</xref></td></tr><tr><td>PEHE motif essential for binding to MOF in vitro</td><td>Morales et al. <xref ref-type="bibr" rid="CR70">2004</xref></td></tr><tr><td rowspan="4">MSL-2 (773aa): RING finger, coiled coil</td><td>MSL-2 RING finger required for interaction with MSL-2 and male viability</td><td>Copps et al. <xref ref-type="bibr" rid="CR23">1998</xref></td></tr><tr><td>Various critical RING finger point mutants fail to rescue <italic>msl-2</italic> flies.</td><td>Lyman et al. <xref ref-type="bibr" rid="CR64">1997</xref></td></tr><tr><td>Sex lethal binds 3&#8242; and 5&#8242; MSL-2 mRNA and inhibits MSL-2 translation in females.</td><td>Bashaw and Baker <xref ref-type="bibr" rid="CR8">1997</xref>; Kelley et al. <xref ref-type="bibr" rid="CR53">1997</xref>; Gebauer et al. <xref ref-type="bibr" rid="CR35">2003</xref></td></tr><tr><td>Ectopic MSL-2 expression causes lethality in females that is dependent on MSL-1 levels.</td><td>Kelley et al. <xref ref-type="bibr" rid="CR52">1995</xref></td></tr><tr><td rowspan="7">MSL-3 (512aa): chromo-barrel domain, MRG domain</td><td>Chromo-barrel domain binds RNA in vitro.</td><td>Akhtar et al. <xref ref-type="bibr" rid="CR4">2000</xref></td></tr><tr><td>Chromo-barrel domain is required for dosage compensation but for targeting of the DCC.</td><td>Buscaino et al. <xref ref-type="bibr" rid="CR15">2006</xref>; Morales et al. <xref ref-type="bibr" rid="CR71">2005</xref></td></tr><tr><td>MSL-3 associates with roX2 RNA in Schneider cells.</td><td>Buscaino et al. <xref ref-type="bibr" rid="CR14">2003</xref></td></tr><tr><td>MSL-3 is acetylated by MOF in vitro and in vivo.</td><td>Buscaino et al. <xref ref-type="bibr" rid="CR14">2003</xref></td></tr><tr><td>DCC binds only to high-affinity sites in MSL-3 mutants.</td><td>Lyman et al. <xref ref-type="bibr" rid="CR64">1997</xref></td></tr><tr><td>MRG domain is required for DCC targeting and assembly.</td><td>Buscaino et al. <xref ref-type="bibr" rid="CR15">2006</xref>; Morales et al. <xref ref-type="bibr" rid="CR71">2005</xref></td></tr><tr><td>MSL-3 interacts directly with MOF and stimulates its HAT activity.</td><td>Morales et al. <xref ref-type="bibr" rid="CR70">2004</xref></td></tr><tr><td rowspan="6">MOF (827aa): chromo-barrel domain, zinc finger, HAT domain</td><td>HAT domain point mutant causes male-specific lethality.</td><td>Hilfiker et al. <xref ref-type="bibr" rid="CR46">1997</xref></td></tr><tr><td>HAT domain required for specific acetylation of H4k16Ac</td><td>Smith et al. <xref ref-type="bibr" rid="CR90">2000</xref>; Akhtar and Becker <xref ref-type="bibr" rid="CR3">2001</xref></td></tr><tr><td>Only enzymatically active MOF activates transcription in vitro.</td><td>Akhtar and Becker <xref ref-type="bibr" rid="CR2">2000</xref></td></tr><tr><td>Chromo-barrel domain binds RNA in vitro.</td><td>Akhtar et al. <xref ref-type="bibr" rid="CR4">2000</xref>; Nielsen et al. <xref ref-type="bibr" rid="CR75">2005</xref></td></tr><tr><td>C2HC zinc finger required for nucleosome binding in vitro</td><td>Akhtar and Becker <xref ref-type="bibr" rid="CR3">2001</xref></td></tr><tr><td>MOF associates with roX2 in vivo in Schneider cells.</td><td>Akhtar et al. <xref ref-type="bibr" rid="CR4">2000</xref>; Mendjan et al. <xref ref-type="bibr" rid="CR68">2006</xref></td></tr><tr><td rowspan="7">MLE (1293aa): dsRNA-binding domain, helicase domain</td><td>Helicase activity on RNA: RNA, RNA: DNA, and DNA: DNA hybrids</td><td>Lee et al. <xref ref-type="bibr" rid="CR58">1997</xref></td></tr><tr><td>ATPase activity and DExD box important for male viability</td><td>Richter et al. <xref ref-type="bibr" rid="CR85">1996</xref></td></tr><tr><td>ATPase activity required for complex spreading along the X</td><td>Lee et al. <xref ref-type="bibr" rid="CR58">1997</xref>; Gu et al. <xref ref-type="bibr" rid="CR41">2000</xref></td></tr><tr><td>Helicase activity essential for roX RNA stability</td><td>Gu et al. <xref ref-type="bibr" rid="CR41">2000</xref></td></tr><tr><td>roX2 associates with MLE in vivo.</td><td>Meller et al. <xref ref-type="bibr" rid="CR67">2000</xref></td></tr><tr><td>The C terminus (941&#8211;1293-aa) can associate with chromatin in an RNAse-sensitive manner.</td><td>Richter et al. <xref ref-type="bibr" rid="CR85">1996</xref></td></tr><tr><td>No action potential (<italic>nap</italic>) allele of MLE required for mRNA processing of <italic>para</italic></td><td>Reenan et al. <xref ref-type="bibr" rid="CR84">2000</xref></td></tr><tr><td rowspan="5">roX1/roX2 (3.7&#160;kb/0.6&#160;kb): roX1 stem loop</td><td>In roX1/roX2 double mutants, the DCC is not properly targeted to the X.</td><td>Meller and Rattner <xref ref-type="bibr" rid="CR65">2002</xref></td></tr><tr><td>MSL-1 and MSL-2 overexpression partially rescues male lethality in roX mutants.</td><td>Oh et al. <xref ref-type="bibr" rid="CR76">2003</xref></td></tr><tr><td>Stem loop in roX1 important for roX1 function</td><td>Stuckenholz et al. <xref ref-type="bibr" rid="CR97">2003</xref></td></tr><tr><td>roX2 variable splicing influences DCC assembly on the X chromosome.</td><td>Park et al. <xref ref-type="bibr" rid="CR81">2005</xref></td></tr><tr><td>Approximately 10% deletions of roX1 do not affect roX function</td><td>Stuckenholz et al. <xref ref-type="bibr" rid="CR97">2003</xref></td></tr></tbody></table></table-wrap>
One of the key questions is how does the MSL complex achieve a twofold increase in transcription on the male X chromosome? One way to get some hints about what activities and molecular mechanisms might be associated with the MSL complex is to analyze its components. MSL proteins contain several domains that are generally implicated in chromatin regulation. MSL1 is a PEHE domain containing protein, MSL2 contains a RING finger and a cysteine-rich cluster, and MSL3 contains a chromo-barrel domain and an MRG domain. MLE and MOF contain enzymatic activities that are associated with the MSL complex. MLE is an RNA/DNA helicase also containing a double-stranded RNA binding domain, and MOF is a histone H4 lysine 16 (H4K16) specific histone acetyltransferase (HAT), which in addition to the HAT domain also contains a chromo-barrel domain and a zinc finger (Fig. 3, Table 1, and references therein). Over the years, several studies using in vitro and in vivo approaches have provided a wealth of information about important interaction regions in MSL proteins as well as roX RNAs. A brief summary of the mapping studies is provided in Table 1 (also see Gilfillan et al. 2004; Rea and Akhtar 2006; and Taipale and Akhtar 2005 for reviews). However, despite several in-depth studies, analysis of MSL proteins continues to provide us with new and interesting insights about the complex properties of MSL proteins. Some of the recent advances are discussed below. Fig. 3Domains in MSL complex members. Schematic representation of domain organization in MSL complex members (not drawn to scale)Table 1Summary of deletion mapping and interaction studies of MSL proteins and roX RNAsMSL complex members (domains/motifs)Functions and interactionsReferencesMSL-1 (1039aa): basic motif, acidic region, coiled coil, PEHE motifProtein region 85-186-aa required for interaction with MSL-2 RING fingerCopps et al. 1998N terminus of MSL-1 required for X-chromosome binding and MSL-1 self-associationLi et al. 2005C terminus interacts with MOF in vivo.Scott et al. 2000A 84-aa N-terminal deletion that still interacts with MSL-2, fails to localize to the X, and causes male lethality.Scott et al. 2000MSL-1 is unstable in MSL-2 mutants, and it is stabilized in MSL-2 overexpressing females.Chang and Kuroda 1998PEHE motif essential for binding to MOF in vitroMorales et al. 2004MSL-2 (773aa): RING finger, coiled coilMSL-2 RING finger required for interaction with MSL-2 and male viabilityCopps et al. 1998Various critical RING finger point mutants fail to rescue msl-2 flies.Lyman et al. 1997Sex lethal binds 3' and 5' MSL-2 mRNA and inhibits MSL-2 translation in females.Bashaw and Baker 1997; Kelley et al. 1997; Gebauer et al. 2003Ectopic MSL-2 expression causes lethality in females that is dependent on MSL-1 levels.Kelley et al. 1995MSL-3 (512aa): chromo-barrel domain, MRG domainChromo-barrel domain binds RNA in vitro.Akhtar et al. 2000Chromo-barrel domain is required for dosage compensation but for targeting of the DCC.Buscaino et al. 2006; Morales et al. 2005MSL-3 associates with roX2 RNA in Schneider cells.Buscaino et al. 2003MSL-3 is acetylated by MOF in vitro and in vivo.Buscaino et al. 2003DCC binds only to high-affinity sites in MSL-3 mutants.Lyman et al. 1997MRG domain is required for DCC targeting and assembly.Buscaino et al. 2006; Morales et al. 2005MSL-3 interacts directly with MOF and stimulates its HAT activity.Morales et al. 2004MOF (827aa): chromo-barrel domain, zinc finger, HAT domainHAT domain point mutant causes male-specific lethality.Hilfiker et al. 1997HAT domain required for specific acetylation of H4k16AcSmith et al. 2000; Akhtar and Becker 2001Only enzymatically active MOF activates transcription in vitro.Akhtar and Becker 2000Chromo-barrel domain binds RNA in vitro.Akhtar et al. 2000; Nielsen et al. 2005C2HC zinc finger required for nucleosome binding in vitroAkhtar and Becker 2001MOF associates with roX2 in vivo in Schneider cells.Akhtar et al. 2000; Mendjan et al. 2006MLE (1293aa): dsRNA-binding domain, helicase domainHelicase activity on RNA: RNA, RNA: DNA, and DNA: DNA hybridsLee et al. 1997ATPase activity and DExD box important for male viabilityRichter et al. 1996ATPase activity required for complex spreading along the XLee et al. 1997; Gu et al. 2000Helicase activity essential for roX RNA stabilityGu et al. 2000roX2 associates with MLE in vivo.Meller et al. 2000The C terminus (941-1293-aa) can associate with chromatin in an RNAse-sensitive manner.Richter et al. 1996No action potential (nap) allele of MLE required for mRNA processing of paraReenan et al. 2000roX1/roX2 (3.7 kb/0.6 kb): roX1 stem loopIn roX1/roX2 double mutants, the DCC is not properly targeted to the X.Meller and Rattner 2002MSL-1 and MSL-2 overexpression partially rescues male lethality in roX mutants.Oh et al. 2003Stem loop in roX1 important for roX1 functionStuckenholz et al. 2003roX2 variable splicing influences DCC assembly on the X chromosome.Park et al. 2005Approximately 10% deletions of roX1 do not affect roX functionStuckenholz et al. 2003
###end p 11
###begin p 12
Domains in MSL complex members. Schematic representation of domain organization in MSL complex members (not drawn to scale)
###end p 12
###begin p 13
Summary of deletion mapping and interaction studies of MSL proteins and roX RNAs
###end p 13
###begin p 14
###xml 173 177 173 177 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR46">1997</xref>
###xml 358 362 358 362 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR2">2000</xref>
###xml 380 384 380 384 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR46">1997</xref>
###xml 531 535 531 535 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR70">2004</xref>
###xml 772 776 772 776 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR10">2006</xref>
###xml 795 799 795 799 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR12">2002</xref>
###xml 817 821 817 821 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR31">2005</xref>
###xml 834 838 834 838 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR69">2003</xref>
###xml 1087 1091 1087 1091 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR95">2000</xref>
###xml 1420 1424 1420 1424 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR75">2005</xref>
###xml 1682 1686 1672 1676 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR74">2002</xref>
###xml 1995 1999 1985 1989 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR4">2000</xref>
###xml 2016 2020 2006 2010 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR75">2005</xref>
One of the best-characterized proteins of the MSL complex is the HAT MOF that specifically acetylates lysine 16 on histone H4 (H4K16Ac) on the X chromosome (Hilfiker et al. 1997). The HAT activity of MOF has been suggested to directly contribute to the stimulation of transcription and therefore has a direct impact on dosage compensation (Akhtar and Becker 2000; Hilfiker et al. 1997). MOF requires to be incorporated into the MSL complex via interactions with MSL3 and MSL1 to exhibit its full enzymatic activity (Morales et al. 2004). As mentioned above besides the HAT domain, MOF contains a chromo-barrel domain similar to MSL3. Chromo-barrel domains have similarity to chromodomains, which have been shown to bind methylated histones, DNA, and RNA (Bernstein et al. 2006; Bouazoune et al. 2002; Flanagan et al. 2005; Min et al. 2003). Chromodomains comprise an essential part of the histone code hypothesis that explains transcriptional regulation through binding and recruitment of specific regulators dependent on specific combinations of histone modifications (Strahl and Allis 2000). Therefore, the question arises if these domains contribute to something like an X chromosomal histone code. The structure of the MOF chromo-barrel domain has revealed that this domain (also present in MSL3) is structurally distinct from the canonical chromodomains found in numerous chromatin-related proteins (Nielsen et al. 2005). MOF chromo-barrel domain is composed of beta-barrels, while the canonical chromodomains have an alpha + beta fold. It is interesting to note that this structure resembles the HP1 chromodomain bound to methylated histone H3 lysine 9 (H3K9) (Nielsen et al. 2002), suggesting that the MOF chromo-barrel domain would not be able to accommodate a methylated histone tail. This poses an interesting question as to the function of MOF chromo-barrel domain. The MOF chromo-barrel domain and its adjacent lysine-rich region are required for RNA binding in vitro (Akhtar et al. 2000; Nielsen et al. 2005). It remains to be seen how this region of MOF mechanistically participates in RNA interaction and whether the chromo-barrel domain may also be able to recognize some other histone modifications.
###end p 14
###begin p 15
###xml 484 488 484 488 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR15">2006</xref>
###xml 747 751 747 751 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR17">2005</xref>
###xml 770 774 770 774 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR51">2005</xref>
###xml 789 793 789 793 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR55">2005</xref>
###xml 655 660 <span type="species:ncbi:4932">yeast</span>
In contrast to MOF, the chromo-barrel domain of MSL3 might be involved in the binding of methylated residues as the aromatic residues required for coordination of methylated lysines are conserved in MSL3. However, mutations in two of the conserved hydrophobic residues in MSL3 chromo-barrel domain do not lead to any visible functional consequences in flies, suggesting that there is no binding in vivo or that additional residues might contribute to the interaction (Buscaino et al. 2006). What residue could be recognized by MSL3 is still a matter of speculation. Histone H3 lysine 36 (H3K36) is a likely candidate because the chromodomain of EAF3, the yeast homologue of MSL3, has recently been shown to bind this modification (Carrozza et al. 2005; Joshi and Struhl 2005; Keogh et al. 2005). However, experimental evidence for such an interaction by MSL3 chromo-barrel domain is still lacking. It would indeed be an interesting possibility if another histone modification in addition to H4K16Ac would contribute to the X-chromosomal epigenetic code.
###end p 15
###begin p 16
###xml 173 177 173 177 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR15">2006</xref>
###xml 194 198 194 198 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR71">2005</xref>
###xml 230 248 230 248 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MORF4-related gene</italic>
###xml 367 371 367 371 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR11">2001</xref>
###xml 500 504 500 504 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR71">2005</xref>
###xml 657 661 657 661 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR15">2006</xref>
###xml 903 907 903 907 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR15">2006</xref>
###xml 298 303 <span type="species:ncbi:4932">yeast</span>
###xml 307 313 <span type="species:ncbi:9606">humans</span>
Deletion analysis of different domains that contribute to the function of MSL3 brought some unexpected insights about the complexity of dosage compensation (Buscaino et al. 2006; Morales et al. 2005). MSL3 contains an MRG domain (MORF4-related gene family) that is found throughout eukaryotes from yeast to humans, with an unknown function (Bertram and Pereira-Smith 2001). This domain is required for proper targeting and integration of MSL3 into the MSL complex on the X chromosome (Morales et al. 2005). However, this is not sufficient to achieve dosage compensation because the chromo-barrel domain is essential for dosage compensation (Buscaino et al. 2006). Hence, the process of dosage compensation contains at least two functionally distinct stages-firstly, recruitment and targeting of the MSL complex to the X chromosome, and secondly, stimulation of X-linked gene expression (Buscaino et al. 2006).
###end p 16
###begin p 17
###xml 371 375 371 375 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR23">1998</xref>
###xml 527 531 527 531 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR61">2005</xref>
###xml 835 839 835 839 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR96">2005</xref>
The multifunctionality of MSL3 illustrates some of the complexities that are involved in the mechanism of dosage compensation. While MOF and MSL3 contain domains clearly involved in chromatin regulation, the role of MSL1 and MSL2 in chromatin regulation is more enigmatic. These proteins interact directly through conserved motifs in the N terminus of MSL1 (Copps et al. 1998). Moreover, the N terminus is also required for the binding of MSL1 to the male X chromosome in vivo and for MSL1 self-association in vitro (Li et al. 2005). Potential MSL1 self-association introduces a perspective that favors a structure-mediated function of the MSL complex. This view is further supported by live cell photo-bleaching experiments with GFP-MSL2, which suggest an extraordinary stable association of MSL2 with the X chromosome (Straub et al. 2005). Consequently, the MSL complex might not be a classical chromatin remodeling complex because at least some of its components do not exhibit the high mobility typical for other chromatin remodeling complexes. It remains possible that stable and specific association of MSLs on X-chromosomal genes induces a specific chromosomal configuration, which is particularly permissive to increased and/or regulated transcription.
###end p 17
###begin p 18
In summary, the characterization of various domains in MSL proteins suggests a role of the MSL complex at more than one level of chromatin regulation. However, the existence of an X-chromosomal epigenetic code remains a pure speculation because the specific interactions between chromatin modules and corresponding histone modification have not been found yet.
###end p 18
###begin title 19
Walking on the X-tracking the footsteps of MSLs
###end title 19
###begin p 20
###xml 72 82 72 82 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Drosophila</italic>
###xml 494 495 494 495 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig2" ref-type="fig">2</xref>
###xml 692 696 692 696 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR57">1991</xref>
###xml 712 716 712 716 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR66">1997</xref>
###xml 913 919 913 919 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in cis</italic>
###xml 980 984 980 984 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR54">1999</xref>
###xml 1191 1195 1191 1195 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR29">2004</xref>
###xml 1207 1211 1207 1211 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR77">2004</xref>
###xml 1516 1520 1516 1520 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR63">2005</xref>
###xml 1632 1635 1632 1635 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cis</italic>
###xml 1641 1646 1641 1646 <italic xmlns:xlink="http://www.w3.org/1999/xlink">trans</italic>
###xml 1980 1984 1980 1984 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR76">2003</xref>
###xml 1998 2002 1998 2002 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR80">2002</xref>
For many years, one of the major questions about dosage compensation in Drosophila has been how MSLs specifically recognize the X and what are the binding sites of the MSL complex on the X chromosome. This is of general interest because there is no simple X-chromosomally specific DNA sequence that could explain the preference of MSLs for the X instead of autosomes. Polytene chromosome spreads have provided a formidable system for visualization of MSL binding on the male X chromosome (Fig. 2). Hundreds of distinct bands bound by the MSL complex can be reproducibly immunostained by specific antibodies against MSL proteins or roX1/2 RNA fluorescence in situ hybridization (Kuroda et al. 1991; Meller et al. 1997). Two of these sites are roX1 and roX2 genomic loci that are bound strongly by the MSL complex. Initially, it was proposed that these are sites of MSL complex assembly, which then further spreads in cis over other binding sites on the X chromosome (Kelley et al. 1999). The characterization of translocations of X fragments to autosomes has led to an alternative model proposing sites on the X chromosome with different affinities for the MSL complex (Fagegaltier and Baker 2004; Oh et al. 2004). The affinity model suggests that there is an X-specific hierarchy of binding affinities for MSL proteins. In addition, there is also a clear hierarchy in complex assembly on the X chromosome that distinguishes MSL1 and MSL2 as essential for further binding of other complex components (Lucchesi et al. 2005). Consequently, specific MSL recruitment to the X chromosome seems to be a complex interplay between different cis- and trans-acting factors. MSL proteins appear to have intrinsic affinity for X-chromosomal sequences, which is tightly balanced with their expression levels and interaction with roX RNAs, as demonstrated by the observations that overexpression of MSL1 and MSL2 complex can partially rescue male lethality in the absence of roX RNAs (Oh et al. 2003; Park et al. 2002).
###end p 20
###begin p 21
###xml 590 594 590 594 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR91">2001</xref>
###xml 740 744 740 744 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR5">2006</xref>
###xml 763 767 763 767 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR37">2006</xref>
###xml 783 787 783 787 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR59">2006</xref>
###xml 978 982 978 982 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR5">2006</xref>
###xml 1001 1005 1001 1005 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR37">2006</xref>
###xml 1230 1234 1230 1234 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR56">2005</xref>
###xml 1250 1254 1250 1254 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR59">2006</xref>
###xml 1461 1465 1461 1465 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR37">2006</xref>
The identification of MSL binding sites in more detail required sophisticated mapping approaches because polytene chromosomes, although very useful, provide limited resolution at the molecular level. The development of functional genomic approaches like chromatin immunoprecipitation coupled with DNA microarrays (ChIP-chip) finally allowed the assessment of this question on a global scale. Previous ChIP experiments suggested that the complex binds some dosage-compensated genes in the 3' coding region, but the question remained whether this also had a global significance (Smith et al. 2001). Three recent studies reported the binding pattern of MSL proteins on the X chromosome using various experimental platforms (Alekseyenko et al. 2006; Gilfillan et al. 2006; Legube et al. 2006). These studies, consistent with earlier observations, revealed the preference of the MSL complex to bind to gene coding regions and in particular to the 3' end of genes (Alekseyenko et al. 2006; Gilfillan et al. 2006). It is interesting to note that studies comparing the binding profiles of MSL1 in embryos and larvae showed that the binding pattern of MSL1 does not dramatically change at different stages of development (Kotlikova et al. 2005; Legube et al. 2006). This is consistent with the additional finding that preferential targets of the MSL binding might be housekeeping/essential genes that are generally expressed throughout fly development (Gilfillan et al. 2006).
###end p 21
###begin p 22
###xml 292 296 292 296 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR56">2005</xref>
###xml 312 316 312 316 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR59">2006</xref>
###xml 421 431 421 431 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Drosophila</italic>
###xml 483 487 483 487 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR5">2006</xref>
###xml 506 510 506 510 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR37">2006</xref>
###xml 526 530 526 530 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR59">2006</xref>
###xml 746 750 746 750 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR86">2003</xref>
Another intriguing question was whether MSL complex binding coincides with RNA polymerase II (RNA-PolII) activity on X-linked genes. Recent observations suggest a weak or no significant correlation between transcription and MSL complex binding, at least, in salivary glands (Kotlikova et al. 2005; Legube et al. 2006). However, correlation of MSL binding with the active state of gene expression in embryos and different Drosophila cell types was indeed observed (Alekseyenko et al. 2006; Gilfillan et al. 2006; Legube et al. 2006). It is therefore likely that tissue-specific differences may influence binding of MSL complex on the X chromosome and that may also in turn be influenced by the expression status of the X-linked genes (Sass et al. 2003). Clearly, the mode of X-chromosomal recognition by the MSL complex is not simple and probably involves multiple steps. Transcription or degenerate DNA elements or subchromosomal context may all contribute to the X-chromosomal specificity of the MSL complex.
###end p 22
###begin title 23
MSLs are not alone-the MSL complex meets other nuclear factors
###end title 23
###begin p 24
###xml 96 97 96 97 <sup xmlns:xlink="http://www.w3.org/1999/xlink">3</sup>
###xml 219 223 219 223 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR72">1965</xref>
###xml 225 229 225 229 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR73">1966</xref>
In 1965, Mukherjee and Beermann analyzed RNA synthesis along the male polytene X chromosome by H3 uridine incorporation and observed increased transcription in comparison to female X chromosomes (Mukherjee and Beermann 1965, 1966). This was the first direct evidence suggesting a role of transcription in dosage compensation. However, despite continuous efforts to discover the components and mechanism of dosage compensation, the question is yet unresolved as to how the MSL complex might impact on transcription.
###end p 24
###begin p 25
Our knowledge about the various single components of the MSL complex does not explain how the specific twofold transcriptional upregulation is achieved. We know that the upregulation is dependent on the MSL complex, but a direct link to the basal machinery that modulates gene expression is missing. One possibility could be that there is no such direct link. The mechanism of dosage compensation could involve novel functions affecting general chromatin configuration in a unique manner. The other possibility is that the MSL complex contains or interacts with additional general factors that would make the link to established regulatory chromatin transcription systems.
###end p 25
###begin p 26
###xml 390 394 390 394 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR49">2000</xref>
###xml 612 616 612 616 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR50">2006</xref>
###xml 748 752 748 752 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR60">2005</xref>
Various levels of chromatin organization are potential regulation points for the mechanism of dosage compensation. There are several reported cases that link the MSL complex to other chromatin-regulating activities/factors. Firstly, there is the JIL1 histone kinase that has been reported to interact with the MSL complex and enriches the X chromosome for H3S10 phosphorylation (Jin et al. 2000). This histone mark has been implicated in chromatin condensation during mitosis and transcription activation, but which of these roles relates to its function in dosage compensation is unclear (Johansen and Johansen 2006). A recent study further suggests a direct involvement of JIL-1 in dosage compensation of genes on the X chromosome (Lerach et al. 2005).
###end p 26
###begin p 27
###xml 145 149 145 149 <italic xmlns:xlink="http://www.w3.org/1999/xlink">iswi</italic>
###xml 257 260 257 260 <italic xmlns:xlink="http://www.w3.org/1999/xlink">mle</italic>
###xml 276 280 276 280 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR25">2002</xref>
###xml 397 401 397 401 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR22">2001</xref>
###xml 584 588 584 588 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR25">2002</xref>
###xml 779 783 779 783 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR38">2004</xref>
###xml 800 804 800 804 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR94">2005</xref>
The second possible connection between dosage compensation and general modulators of chromatin state is the chromatin remodeling factor ISWI. In iswi mutant male larvae, the X chromosome appears puffed, and this phenotype can be suppressed by a mutation in mle (Corona et al. 2002). In addition, acetylation at H4K16 by MOF in vitro inhibits binding of ISWI to chromatin templates (Clapier et al. 2001). Accordingly, it has been suggested that there is a balance between ISWI and MSL complex components, which ensures proper chromatin configuration of the X chromosome (Corona et al. 2002). Recent studies suggest a role of the general chromatin factors such as GAGA, Su(var)3-7, and HP-1 in structure maintenance of the X chromosome and in dosage compensation (Greenberg et al. 2004; Spierer et al. 2005).
###end p 27
###begin p 28
###xml 318 328 318 328 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Drosophila</italic>
###xml 424 428 424 428 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR68">2006</xref>
###xml 443 447 443 447 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR92">2005</xref>
###xml 333 338 <span type="species:ncbi:9606">human</span>
As discussed above, the MSL complex can be genetically and functionally linked to various general chromatin factors. However, a direct biochemical link of such factors to MSL complex components nor their connection to the mechanism of dosage compensation has not been shown. The recent biochemical purification of the Drosophila and human MSL complexes was therefore bringing some new complementary insights (Mendjan et al. 2006; Smith et al. 2005).
###end p 28
###begin p 29
###xml 24 34 24 34 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Drosophila</italic>
###xml 1132 1136 1132 1136 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR68">2006</xref>
The purification of the Drosophila MSL complexes via tagged MOF and MSL3 proteins leads to a number of unexpected observations. The first surprise was that the purifications did not contain some of the expected suspects like MLE, JIL-1, or ISWI. Weak interactions and/or unfavorable purification conditions may be the reason for their absence. The second surprise was that none of the classical transcription-associated factors was found associated with MOF or MSL3. Instead, there seems to be a core MSL complex (containing MSL1, MSL2, MSL3, and MOF) that copurifies with nuclear pore components or associated proteins (Mtor, Nup153, Nup160, Nup98, and Nup154), interband binding proteins (Z4, Chromator/Chriz), and exosome components (Rrp6, Dis3) as well as a number of novel interaction partners. It is interesting to note that of the several proteins tested in this study, only the depletion of nuclear pore associated proteins Mtor and Nup153 by RNA interference led to the loss of both classical immunostaining of MSL proteins on the X chromosome and dosage compensation of at least a subset of X-linked genes (Mendjan et al. 2006). To date, these proteins are unique, apart from the MSLs themselves, in showing such a severe reduction of MSL staining on the X chromosome as a result of their depletion.
###end p 29
###begin title 30
The mechanism of dosage compensation-many hints but no clear answers
###end title 30
###begin p 31
###xml 585 589 585 589 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR5">2006</xref>
###xml 608 612 608 612 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR26">2006</xref>
###xml 631 635 631 635 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR37">2006</xref>
###xml 651 655 651 655 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR59">2006</xref>
Despite much progress in our understanding of MSL interactions with each other or the male X chromosome, it remains a major challenge to decipher the mechanism by which the MSL complex affects gene expression. It has become increasingly clear that dosage compensation involves multiple steps that need to be characterized. The first step comprises the specific recruitment of the MSL complex to the X chromosome. To date, no simple DNA element that would make the X chromosome easily distinguishable from autosomes and allow specific binding of MSLs has been found (Alekseyenko et al. 2006; Dahlsveen et al. 2006; Gilfillan et al. 2006; Legube et al. 2006). This, however, does not mean that the DNA component of chromatin has no role in MSL complex recruitment. Advanced bioinformatic analysis of the X chromosome might lead to the discovery of more complex DNA sequence information that gives some specificity to the X chromosome. In addition, the epigenetic state, specific chromatin configuration, transcription, and degenerated DNA elements could in some combination give the signal for MSL binding.
###end p 31
###begin p 32
###xml 106 107 106 107 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig4" ref-type="fig">4</xref>
###xml 452 456 452 456 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR2">2000</xref>
###xml 801 805 801 805 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR48">2001</xref>
###xml 824 828 824 828 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR95">2000</xref>
###xml 1096 1100 1096 1100 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR5">2006</xref>
###xml 1119 1123 1119 1123 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR37">2006</xref>
###xml 1139 1143 1139 1143 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR59">2006</xref>
###xml 1158 1162 1158 1162 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR91">2001</xref>
###xml 1325 1326 1325 1326 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig4" ref-type="fig">4</xref>
###xml 1351 1355 1351 1355 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR45">1993</xref>
###xml 1370 1374 1370 1374 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR91">2001</xref>
###xml 1554 1558 1554 1558 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR78">2000</xref>
###xml 1570 1574 1570 1574 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR98">2002</xref>
###xml 1734 1738 1734 1738 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR28">2003</xref>
###xml 1761 1765 1761 1765 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR89">2006</xref>
###xml 1794 1798 1794 1798 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR88">2006</xref>
###xml 1979 1985 1979 1985 <label xmlns:xlink="http://www.w3.org/1999/xlink">Fig.&#160;4</label>
###xml 2021 2022 2021 2022 <bold xmlns:xlink="http://www.w3.org/1999/xlink">a</bold>
###xml 2280 2293 2280 2293 <italic xmlns:xlink="http://www.w3.org/1999/xlink">question mark</italic>
###xml 2322 2330 2322 2330 <italic xmlns:xlink="http://www.w3.org/1999/xlink">asterisk</italic>
###xml 2369 2381 2369 2381 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gray circles</italic>
###xml 2425 2451 2425 2451 <italic xmlns:xlink="http://www.w3.org/1999/xlink">by purple and orange ovals</italic>
###xml 2510 2527 2510 2527 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gray wiggled line</italic>
###xml 2529 2530 2529 2530 <bold xmlns:xlink="http://www.w3.org/1999/xlink">b</bold>
###xml 2677 2680 2677 2680 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NPC</italic>
###xml 2702 2706 2702 2706 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR5">2006</xref>
###xml 2725 2729 2725 2729 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR37">2006</xref>
###xml 2746 2750 2746 2750 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR68">2006</xref>
###xml 2765 2769 2765 2769 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR91">2001</xref>
###xml 2961 2968 2961 2968 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Model 1</italic>
###xml 3221 3225 3221 3225 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR19">2005</xref>
###xml 3349 3353 3349 3353 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR16">2006</xref>
###xml 3369 3373 3369 3373 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR99">2006</xref>
###xml 3431 3441 3431 3441 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Drosophila</italic>
###xml 3757 3764 3757 3764 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Model 2</italic>
###xml 4439 4446 4439 4446 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Model 3</italic>
###xml 4545 4555 4545 4555 <italic xmlns:xlink="http://www.w3.org/1999/xlink">models 1&#8211;3</italic>
###xml 1985 4680 1985 4680 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="33">Dosage compensation working models. <bold>a</bold> The current predominant model of dosage compensation proposes transcription elongation as the main regulating point of the MSL complex. How this is achieved on the molecular level and what is the role of H4K16 acetylation is not yet known (represented by a <italic>question mark</italic>). H4K16Ac is represented by <italic>asterisk</italic>, while nucleosomes are represented by <italic>gray circles</italic>. MSL complex and RNA PolII are represented <italic>by purple and orange ovals</italic>, respectively. X-chromosomal transcript is represented by <italic>gray wiggled line</italic>. <bold>b</bold> MSL proteins are enriched on the 3&#8242; end of X-linked genes, and they have been found to be associated with components of the nuclear pore complex (<italic>NPC</italic>) (Alekseyenko et al. <xref ref-type="bibr" rid="CR5">2006</xref>; Gilfillan et al. <xref ref-type="bibr" rid="CR37">2006</xref>; Mendjan et al. <xref ref-type="bibr" rid="CR68">2006</xref>; Smith et al. <xref ref-type="bibr" rid="CR91">2001</xref>). Consequently, speculative models for the molecular mechanism of dosage compensation can be envisaged that could stimulate our thinking about how MSLs might affect transcription elongation. <italic>Model 1</italic> proposes that MSL&#8211;NPC interactions might create a specialized X-chromosomal compartment or domain. This model is based on observations in yeast, where the orthologue of Mtor (Mlp1) has been shown to bind transcriptionally active genes (Casolari et al. <xref ref-type="bibr" rid="CR19">2005</xref>). Furthermore, transcriptional activity of a gene has the potential to be modulated at the nuclear periphery (Cabal et al. <xref ref-type="bibr" rid="CR16">2006</xref>; Taddei et al. <xref ref-type="bibr" rid="CR99">2006</xref>). In manner similar to yeast, nuclear pore components in <italic>Drosophila</italic> may also facilitate modulation of transcriptional activity. This can be achieved by organizing chromatin into functional domains. The X chromosome may therefore require such organization to create functional territories where the MSL complex can act cooperatively to regulate the expression of many X-linked genes. <italic>Model 2</italic> proposes that MSLs may link the X chromosome with the nuclear exosome and the NPC and therefore facilitate coupling of transcription elongation and posttranscriptional events such as RNA processing or export. Another interesting possibility is that nuclear pore components like Mtor and/or Nup153 might be involved in efficient processing and maturation of roX RNAs and their efficient incorporation into the MSL complex. The question remains whether these effects are really a consequence of physical tethering of chromatin and/or RNA to the pore or whether dynamic behavior of pore components facilitates such interaction and therefore does not need to occur at the pore. <italic>Model 3</italic> therefore suggests a nuclear pore independent function of Mtor and Nup153 in gene regulation. The <italic>models 1&#8211;3</italic> are not mutually exclusive, and depending on the circumstance, one or more modules may contribute to fine tune gene activity</p>
###xml 1985 4680 1985 4680 <caption xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="33">Dosage compensation working models. <bold>a</bold> The current predominant model of dosage compensation proposes transcription elongation as the main regulating point of the MSL complex. How this is achieved on the molecular level and what is the role of H4K16 acetylation is not yet known (represented by a <italic>question mark</italic>). H4K16Ac is represented by <italic>asterisk</italic>, while nucleosomes are represented by <italic>gray circles</italic>. MSL complex and RNA PolII are represented <italic>by purple and orange ovals</italic>, respectively. X-chromosomal transcript is represented by <italic>gray wiggled line</italic>. <bold>b</bold> MSL proteins are enriched on the 3&#8242; end of X-linked genes, and they have been found to be associated with components of the nuclear pore complex (<italic>NPC</italic>) (Alekseyenko et al. <xref ref-type="bibr" rid="CR5">2006</xref>; Gilfillan et al. <xref ref-type="bibr" rid="CR37">2006</xref>; Mendjan et al. <xref ref-type="bibr" rid="CR68">2006</xref>; Smith et al. <xref ref-type="bibr" rid="CR91">2001</xref>). Consequently, speculative models for the molecular mechanism of dosage compensation can be envisaged that could stimulate our thinking about how MSLs might affect transcription elongation. <italic>Model 1</italic> proposes that MSL&#8211;NPC interactions might create a specialized X-chromosomal compartment or domain. This model is based on observations in yeast, where the orthologue of Mtor (Mlp1) has been shown to bind transcriptionally active genes (Casolari et al. <xref ref-type="bibr" rid="CR19">2005</xref>). Furthermore, transcriptional activity of a gene has the potential to be modulated at the nuclear periphery (Cabal et al. <xref ref-type="bibr" rid="CR16">2006</xref>; Taddei et al. <xref ref-type="bibr" rid="CR99">2006</xref>). In manner similar to yeast, nuclear pore components in <italic>Drosophila</italic> may also facilitate modulation of transcriptional activity. This can be achieved by organizing chromatin into functional domains. The X chromosome may therefore require such organization to create functional territories where the MSL complex can act cooperatively to regulate the expression of many X-linked genes. <italic>Model 2</italic> proposes that MSLs may link the X chromosome with the nuclear exosome and the NPC and therefore facilitate coupling of transcription elongation and posttranscriptional events such as RNA processing or export. Another interesting possibility is that nuclear pore components like Mtor and/or Nup153 might be involved in efficient processing and maturation of roX RNAs and their efficient incorporation into the MSL complex. The question remains whether these effects are really a consequence of physical tethering of chromatin and/or RNA to the pore or whether dynamic behavior of pore components facilitates such interaction and therefore does not need to occur at the pore. <italic>Model 3</italic> therefore suggests a nuclear pore independent function of Mtor and Nup153 in gene regulation. The <italic>models 1&#8211;3</italic> are not mutually exclusive, and depending on the circumstance, one or more modules may contribute to fine tune gene activity</p></caption>
###xml 4680 4680 4680 4680 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="anchor" xlink:href="412_2006_89_Fig4_HTML" id="MO4"/>
###xml 1979 4680 1979 4680 <fig xmlns:xlink="http://www.w3.org/1999/xlink" id="Fig4"><label>Fig.&#160;4</label><caption><p textid="33">Dosage compensation working models. <bold>a</bold> The current predominant model of dosage compensation proposes transcription elongation as the main regulating point of the MSL complex. How this is achieved on the molecular level and what is the role of H4K16 acetylation is not yet known (represented by a <italic>question mark</italic>). H4K16Ac is represented by <italic>asterisk</italic>, while nucleosomes are represented by <italic>gray circles</italic>. MSL complex and RNA PolII are represented <italic>by purple and orange ovals</italic>, respectively. X-chromosomal transcript is represented by <italic>gray wiggled line</italic>. <bold>b</bold> MSL proteins are enriched on the 3&#8242; end of X-linked genes, and they have been found to be associated with components of the nuclear pore complex (<italic>NPC</italic>) (Alekseyenko et al. <xref ref-type="bibr" rid="CR5">2006</xref>; Gilfillan et al. <xref ref-type="bibr" rid="CR37">2006</xref>; Mendjan et al. <xref ref-type="bibr" rid="CR68">2006</xref>; Smith et al. <xref ref-type="bibr" rid="CR91">2001</xref>). Consequently, speculative models for the molecular mechanism of dosage compensation can be envisaged that could stimulate our thinking about how MSLs might affect transcription elongation. <italic>Model 1</italic> proposes that MSL&#8211;NPC interactions might create a specialized X-chromosomal compartment or domain. This model is based on observations in yeast, where the orthologue of Mtor (Mlp1) has been shown to bind transcriptionally active genes (Casolari et al. <xref ref-type="bibr" rid="CR19">2005</xref>). Furthermore, transcriptional activity of a gene has the potential to be modulated at the nuclear periphery (Cabal et al. <xref ref-type="bibr" rid="CR16">2006</xref>; Taddei et al. <xref ref-type="bibr" rid="CR99">2006</xref>). In manner similar to yeast, nuclear pore components in <italic>Drosophila</italic> may also facilitate modulation of transcriptional activity. This can be achieved by organizing chromatin into functional domains. The X chromosome may therefore require such organization to create functional territories where the MSL complex can act cooperatively to regulate the expression of many X-linked genes. <italic>Model 2</italic> proposes that MSLs may link the X chromosome with the nuclear exosome and the NPC and therefore facilitate coupling of transcription elongation and posttranscriptional events such as RNA processing or export. Another interesting possibility is that nuclear pore components like Mtor and/or Nup153 might be involved in efficient processing and maturation of roX RNAs and their efficient incorporation into the MSL complex. The question remains whether these effects are really a consequence of physical tethering of chromatin and/or RNA to the pore or whether dynamic behavior of pore components facilitates such interaction and therefore does not need to occur at the pore. <italic>Model 3</italic> therefore suggests a nuclear pore independent function of Mtor and Nup153 in gene regulation. The <italic>models 1&#8211;3</italic> are not mutually exclusive, and depending on the circumstance, one or more modules may contribute to fine tune gene activity</p></caption><graphic position="anchor" xlink:href="412_2006_89_Fig4_HTML" id="MO4"/></fig>
###xml 365 370 <span type="species:ncbi:4932">yeast</span>
###xml 3107 3112 <span type="species:ncbi:4932">yeast</span>
###xml 3397 3402 <span type="species:ncbi:4932">yeast</span>
The second step of dosage compensation is the twofold upregulation of gene expression on the male X (Fig. 4a). Could the histone modification by MOF be the key to the mechanism of dosage compensation? Acetylation of H4K16 by MOF has been shown to cause derepression of transcription either in an in vitro transcription system or when tethered to a reporter gene in yeast; however, the effects were more than twofold in these systems (Akhtar and Becker 2000). There is a possibility that all the other complex components solely help to target and correctly distribute MOF at the X chromosome, while H4K16 acetylation does the actual job. How could this be achieved? The histone code hypothesis predicted correctly, in some cases, that specific effector proteins bind distinct marks (Jenuwein and Allis 2001; Strahl and Allis 2000). However, the receptor (possibly a bromodomain-containing protein) for H4K16Ac has not been found yet. The local distribution of this mark and MSL proteins along gene coding regions implies transcription elongation as a possible regulation point (Alekseyenko et al. 2006; Gilfillan et al. 2006; Legube et al. 2006; Smith et al. 2001). These data are in agreement with the current model of dosage compensation that implies a role of the MSL complex in facilitating transcription elongation (Fig. 4a) (Henikoff and Meneely 1993; Smith et al. 2001). In general, histone acetylation has been already suggested to enhance transcription, but this has not been specifically demonstrated for the H4K16 mark (Orphanides and Reinberg 2000; Svejstrup 2002). It is important to note however that the H4K16 residue is directly implicated in higher-order chromatin structure based on structural studies (Dorigo et al. 2003; Shogren-Knaak et al. 2006; Shogren-Knaak and Peterson 2006). Thus, the effect of H4K16 modification that ultimately leads to dosage compensation may involve levels of chromatin organization and function, which are still poorly understood. Fig. 4Dosage compensation working models. a The current predominant model of dosage compensation proposes transcription elongation as the main regulating point of the MSL complex. How this is achieved on the molecular level and what is the role of H4K16 acetylation is not yet known (represented by a question mark). H4K16Ac is represented by asterisk, while nucleosomes are represented by gray circles. MSL complex and RNA PolII are represented by purple and orange ovals, respectively. X-chromosomal transcript is represented by gray wiggled line. b MSL proteins are enriched on the 3' end of X-linked genes, and they have been found to be associated with components of the nuclear pore complex (NPC) (Alekseyenko et al. 2006; Gilfillan et al. 2006; Mendjan et al. 2006; Smith et al. 2001). Consequently, speculative models for the molecular mechanism of dosage compensation can be envisaged that could stimulate our thinking about how MSLs might affect transcription elongation. Model 1 proposes that MSL-NPC interactions might create a specialized X-chromosomal compartment or domain. This model is based on observations in yeast, where the orthologue of Mtor (Mlp1) has been shown to bind transcriptionally active genes (Casolari et al. 2005). Furthermore, transcriptional activity of a gene has the potential to be modulated at the nuclear periphery (Cabal et al. 2006; Taddei et al. 2006). In manner similar to yeast, nuclear pore components in Drosophila may also facilitate modulation of transcriptional activity. This can be achieved by organizing chromatin into functional domains. The X chromosome may therefore require such organization to create functional territories where the MSL complex can act cooperatively to regulate the expression of many X-linked genes. Model 2 proposes that MSLs may link the X chromosome with the nuclear exosome and the NPC and therefore facilitate coupling of transcription elongation and posttranscriptional events such as RNA processing or export. Another interesting possibility is that nuclear pore components like Mtor and/or Nup153 might be involved in efficient processing and maturation of roX RNAs and their efficient incorporation into the MSL complex. The question remains whether these effects are really a consequence of physical tethering of chromatin and/or RNA to the pore or whether dynamic behavior of pore components facilitates such interaction and therefore does not need to occur at the pore. Model 3 therefore suggests a nuclear pore independent function of Mtor and Nup153 in gene regulation. The models 1-3 are not mutually exclusive, and depending on the circumstance, one or more modules may contribute to fine tune gene activity
###end p 32
###begin p 33
###xml 36 37 36 37 <bold xmlns:xlink="http://www.w3.org/1999/xlink">a</bold>
###xml 295 308 295 308 <italic xmlns:xlink="http://www.w3.org/1999/xlink">question mark</italic>
###xml 337 345 337 345 <italic xmlns:xlink="http://www.w3.org/1999/xlink">asterisk</italic>
###xml 384 396 384 396 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gray circles</italic>
###xml 440 466 440 466 <italic xmlns:xlink="http://www.w3.org/1999/xlink">by purple and orange ovals</italic>
###xml 525 542 525 542 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gray wiggled line</italic>
###xml 544 545 544 545 <bold xmlns:xlink="http://www.w3.org/1999/xlink">b</bold>
###xml 692 695 692 695 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NPC</italic>
###xml 717 721 717 721 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR5">2006</xref>
###xml 740 744 740 744 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR37">2006</xref>
###xml 761 765 761 765 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR68">2006</xref>
###xml 780 784 780 784 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR91">2001</xref>
###xml 976 983 976 983 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Model 1</italic>
###xml 1236 1240 1236 1240 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR19">2005</xref>
###xml 1364 1368 1364 1368 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR16">2006</xref>
###xml 1384 1388 1384 1388 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR99">2006</xref>
###xml 1446 1456 1446 1456 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Drosophila</italic>
###xml 1772 1779 1772 1779 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Model 2</italic>
###xml 2454 2461 2454 2461 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Model 3</italic>
###xml 2560 2570 2560 2570 <italic xmlns:xlink="http://www.w3.org/1999/xlink">models 1&#8211;3</italic>
###xml 1122 1127 <span type="species:ncbi:4932">yeast</span>
###xml 1412 1417 <span type="species:ncbi:4932">yeast</span>
Dosage compensation working models. a The current predominant model of dosage compensation proposes transcription elongation as the main regulating point of the MSL complex. How this is achieved on the molecular level and what is the role of H4K16 acetylation is not yet known (represented by a question mark). H4K16Ac is represented by asterisk, while nucleosomes are represented by gray circles. MSL complex and RNA PolII are represented by purple and orange ovals, respectively. X-chromosomal transcript is represented by gray wiggled line. b MSL proteins are enriched on the 3' end of X-linked genes, and they have been found to be associated with components of the nuclear pore complex (NPC) (Alekseyenko et al. 2006; Gilfillan et al. 2006; Mendjan et al. 2006; Smith et al. 2001). Consequently, speculative models for the molecular mechanism of dosage compensation can be envisaged that could stimulate our thinking about how MSLs might affect transcription elongation. Model 1 proposes that MSL-NPC interactions might create a specialized X-chromosomal compartment or domain. This model is based on observations in yeast, where the orthologue of Mtor (Mlp1) has been shown to bind transcriptionally active genes (Casolari et al. 2005). Furthermore, transcriptional activity of a gene has the potential to be modulated at the nuclear periphery (Cabal et al. 2006; Taddei et al. 2006). In manner similar to yeast, nuclear pore components in Drosophila may also facilitate modulation of transcriptional activity. This can be achieved by organizing chromatin into functional domains. The X chromosome may therefore require such organization to create functional territories where the MSL complex can act cooperatively to regulate the expression of many X-linked genes. Model 2 proposes that MSLs may link the X chromosome with the nuclear exosome and the NPC and therefore facilitate coupling of transcription elongation and posttranscriptional events such as RNA processing or export. Another interesting possibility is that nuclear pore components like Mtor and/or Nup153 might be involved in efficient processing and maturation of roX RNAs and their efficient incorporation into the MSL complex. The question remains whether these effects are really a consequence of physical tethering of chromatin and/or RNA to the pore or whether dynamic behavior of pore components facilitates such interaction and therefore does not need to occur at the pore. Model 3 therefore suggests a nuclear pore independent function of Mtor and Nup153 in gene regulation. The models 1-3 are not mutually exclusive, and depending on the circumstance, one or more modules may contribute to fine tune gene activity
###end p 33
###begin p 34
###xml 102 103 102 103 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig4" ref-type="fig">4</xref>
###xml 504 505 504 505 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig4" ref-type="fig">4</xref>
The local enrichment of MSLs at the 3' end of genes supports the transcription elongation model (Fig. 4a); however, the mere presence of MSL proteins at the 3' end of genes is not sufficient to explain mechanistically how MSLs might help facilitate efficient elongation. Integration of the recent data concerning copurification of nuclear pore components and exosome components with MSL proteins into the elongation model of dosage compensation may help to conceptualize how this might be achieved (Fig. 4b).
###end p 34
###begin p 35
###xml 185 189 185 189 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR19">2005</xref>
###xml 208 212 208 212 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR30">2002</xref>
###xml 234 244 234 244 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Drosophila</italic>
###xml 396 397 396 397 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig4" ref-type="fig">4</xref>
###xml 818 822 818 822 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR16">2006</xref>
###xml 838 842 838 842 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR99">2006</xref>
###xml 989 993 989 993 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR99">2006</xref>
###xml 1117 1121 1117 1121 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR5">2006</xref>
###xml 1140 1144 1140 1144 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR37">2006</xref>
###xml 1159 1163 1159 1163 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR91">2001</xref>
###xml 35 40 <span type="species:ncbi:4932">yeast</span>
###xml 699 704 <span type="species:ncbi:4932">yeast</span>
One model, drawn from analogies to yeast, is that nuclear pore components may influence dosage compensation through chromatin loop organization and spatial positioning (Casolari et al. 2005; Feuerbach et al. 2002). Mtor and Nup153 in Drosophila Schneider cells could affect specific gene or chromosomal domain organization that is required for subsequent mechanisms of chromatin regulation (Fig. 4b, model 1). This model implies that Mtor and Nup153 are indirectly involved in the upregulation of transcription by participating in a higher hierarchical level of chromatin organization and compartmentalization. How important this aspect can be for optimal gene expression was nicely demonstrated in yeast for galactose-inducible genes that require association with the nuclear pore for optimal induction (Cabal et al. 2006; Taddei et al. 2006). It is interesting to note that for HKX1 gene, localization to the nuclear periphery required sequences at the 3' end of the gene (Taddei et al. 2006). There are some intriguing parallels with enriched binding of MSL complex also at the 3' end of genes (Alekseyenko et al. 2006; Gilfillan et al. 2006; Smith et al. 2001). However, the significance of this enrichment remains to be explored.
###end p 35
###begin p 36
###xml 173 174 173 174 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig4" ref-type="fig">4</xref>
###xml 381 385 381 385 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR93">2005</xref>
###xml 562 566 562 566 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR34">2004</xref>
###xml 705 709 705 709 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR62">2002</xref>
###xml 728 732 728 732 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR101">2002</xref>
###xml 862 866 862 866 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR7">2002</xref>
###xml 1010 1014 1010 1014 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR18">2004</xref>
###xml 1032 1036 1032 1036 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR47">2001</xref>
###xml 1051 1055 1051 1055 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR62">2002</xref>
###xml 1196 1206 1196 1206 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Drosophila</italic>
###xml 354 359 <span type="species:ncbi:4932">yeast</span>
###xml 1137 1142 <span type="species:ncbi:4932">yeast</span>
The second model is that Mtor/Nup153 might have a more direct role on gene expression machinery by linking X-chromosomal transcripts and regulatory exosome components (Fig. 4b, model 2). Most of the data concerning the role of the exosome in RNA surveillance, coupling with transcription elongation, and collaboration with Mlp/Mtor have been obtained in yeast (Sommer and Nehrbass 2005). The exosome components Rrp6 and Dis3 participate at different steps of mRNA maturation, and they collaborate with the Mlps at essential steps of gene expression (Galy et al. 2004). Recent work has linked the exosome (Rrp6 subunit) to the TREX complex that is thought to couple transcription with export (Libri et al. 2002; Zenklusen et al. 2002). Moreover, the exosome is recruited to active genes through interactions with transcription elongating factors (Andrulis et al. 2002). The Rrp6 subunit has been implicated in quality control of mRNP particles already at a very early step during transcription (Casolari et al. 2004; Hilleren et al. 2001; Libri et al. 2002). The factors that ultimately link the exosome and Mlp proteins are not known in yeast, and whether the MSLs might fulfill this function in Drosophila is a matter of speculation.
###end p 36
###begin p 37
###xml 144 148 144 148 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR4">2000</xref>
###xml 166 170 166 170 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR14">2003</xref>
###xml 187 191 187 191 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR85">1996</xref>
###xml 699 703 699 703 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR47">2001</xref>
###xml 722 726 722 726 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR101">2002</xref>
###xml 1255 1259 1255 1259 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR21">2006</xref>
###xml 1385 1395 1385 1395 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Drosophila</italic>
What would be the role of the MSL proteins in this context? At least three MSLs (MOF, MSL3, and MLE) have been shown to bind RNA (Akhtar et al. 2000; Buscaino et al. 2003; Richter et al. 1996). In addition, two of them (MOF and MSL3) copurify Mtor, suggesting that they could have a mediating role between chromatin, transcription, and pre-mRNA processing. There is a possibility that cotranscriptional pre-mRNA processing represents the point of MSL regulation. The MSL complex could specifically facilitate spatial, cotranscriptional coupling between events in gene expression of X-chromosomal genes. The exosome is involved in the processing and quality control of various mRNPs (Hilleren et al. 2001; Zenklusen et al. 2002). Consequently, it might also be required for processing and subsequent assembly of roX RNAs into the MSL complex. roX2 RNA has been shown to undergo variable splicing that contributes to its function in dosage compensation (Park 2005), raising the possibility that other roX RNA processing events might also be critical. It is also interesting to note that a recent study demonstrated the importance of exosome components for Xist RNA processing that is essential for proper X-chromosome inactivation in mammals (Ciaudo et al. 2006). Future studies on roX RNA processing might uncover another interesting parallel between the dosage compensation systems in Drosophila and mammals.
###end p 37
###begin p 38
###xml 215 216 215 216 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig4" ref-type="fig">4</xref>
###xml 402 406 402 406 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR24">1997</xref>
###xml 423 427 423 427 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR39">2002</xref>
###xml 429 433 429 433 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR40">2004</xref>
###xml 451 455 451 455 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR42">2003</xref>
###xml 469 473 469 473 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR43">2001</xref>
###xml 488 492 488 492 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR82">2004</xref>
###xml 510 514 510 514 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR102">1997</xref>
Finally, it can be envisaged that nuclear pore complex members may also function outside of their predominant role as members of the nuclear pore and act as independent submodules for regulating gene activity (Fig. 4b, model 3). Consistent with this hypothesis, a number of nuclear pore components have been shown to display dynamic behavior or exist as soluble pools in the nucleoplasm (Cordes et al. 1997; Griffis et al. 2002, 2004; Hase and Cordes 2003; Hase et al. 2001; Rabut et al. 2004; Zimowska et al. 1997). In this scenario, limited soluble pools of these proteins may bind genic or intergenic regions to function as activators or repressors and in this capacity affect X-chromosomal as well as autosomal gene expression. It is important to note that neither of the above scenarios is mutually exclusive, and combined action of different steps may result in the twofold impact on transcription.
###end p 38
###begin p 39
###xml 99 109 99 109 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Drosophila</italic>
In summary, recent studies have made important advances in our knowledge of dosage compensation in Drosophila. They highlight the complexity behind the twofold upregulation of transcription and various levels of chromosomal regulation and gene expression control that might participate in it. One thing is clear: the dosage compensation process will continue to fascinate us for quite sometime to come.
###end p 39
###begin title 40
Acknowledgements
###end title 40
###begin p 41
We are very grateful to Max Scott, Wolfram Antonin, and Kent Duncan for their critical reading of this manuscript. We thank the members of the lab for their helpful discussions and Maj Britt Hansen for the help with the figures. We also thank the referees for their helpful suggestions. This work was supported by the "Epigenome" NoE under EU-FP6 and DFG "Epigenetics".
###end p 41
###begin title 42
References
###end title 42
###begin article-title 43
Dosage compensation: an intertwined world of RNA and chromatin remodelling
###end article-title 43
###begin article-title 44
Activation of transcription through histone H4 acetylation by MOF, an acetyl transferase essential for dosage compensation in Drosophila
###end article-title 44
###begin article-title 45
The histone H4 acetyltransferase MOF uses a C2HC zinc finger for substrate recognition
###end article-title 45
###begin article-title 46
Chromodomains as RNA interaction modules
###end article-title 46
###begin article-title 47
High-resolution ChIP-chip analysis reveals that the Drosophila MSL complex selectively identifies active genes on the male X chromosome
###end article-title 47
###begin article-title 48
Genes expressed in neurons of adult male Drosophila
###end article-title 48
###begin article-title 49
The RNA processing exosome is linked to elongating RNA polymerase II in Drosophila
###end article-title 49
###begin article-title 50
The regulation of the Drosophila msl-2 gene reveals a function for Sex-lethal in translational control
###end article-title 50
###begin article-title 51
Control of X chromosome transcription by the maleless gene in Drosophila
###end article-title 51
###begin article-title 52
###xml 0 5 <span type="species:ncbi:10090">Mouse</span>
Mouse polycomb proteins bind differentially to methylated histone H3 and RNA and are enriched in facultative heterochromatin
###end article-title 52
###begin article-title 53
Conservation of the MORF4 related gene family: identification of a new chromo domain subfamily and novel protein motif
###end article-title 53
###begin article-title 54
The dMi-2 chromodomains are DNA binding modules important for ATP-dependent nucleosome mobilization
###end article-title 54
###begin article-title 55
Sex in relation to chromosomes and genes
###end article-title 55
###begin article-title 56
MOF-regulated acetylation of MSL-3 in the Drosophila dosage compensation complex
###end article-title 56
###begin article-title 57
X-chromosome targeting and dosage compensation are mediated by distinct domains in MSL-3
###end article-title 57
###begin article-title 58
SAGA interacting factors confine sub-diffusion of transcribed genes to the nuclear envelope
###end article-title 58
###begin article-title 59
Histone H3 methylation by Set2 directs deacetylation of coding regions by Rpd3S to suppress spurious intragenic transcription
###end article-title 59
###begin article-title 60
Genome-wide localization of the nuclear transport machinery couples transcriptional status and nuclear organization
###end article-title 60
###begin article-title 61
Developmentally induced changes in transcriptional program alter spatial organization across chromosomes
###end article-title 61
###begin article-title 62
Modulation of MSL1 abundance in female Drosophila contributes to the sex specificity of dosage compensation
###end article-title 62
###begin article-title 63
Nuclear mRNA degradation pathway(s) are implicated in Xist regulation and X chromosome inactivation
###end article-title 63
###begin article-title 64
Critical role for the histone H4 N terminus in nucleosome remodeling by ISWI
###end article-title 64
###begin article-title 65
Complex formation by the Drosophila MSL proteins: role of the MSL2 RING finger in protein complex assembly
###end article-title 65
###begin article-title 66
Identification of protein p270/Tpr as a constitutive component of the nuclear pore complex-attached intranuclear filaments
###end article-title 66
###begin article-title 67
Modulation of ISWI function by site-specific histone acetylation
###end article-title 67
###begin article-title 68
Targeting determinants of dosage compensation in Drosophila
###end article-title 68
###begin article-title 69
###xml 84 107 <span type="species:ncbi:7227">Drosophila melanogaster</span>
The MSL complex levels are critical for its correct targeting to the chromosomes in Drosophila melanogaster
###end article-title 69
###begin article-title 70
Chromatin fiber folding: requirement for the histone H4 N-terminal tail
###end article-title 70
###begin article-title 71
X chromosome sites autonomously recruit the dosage compensation complex in Drosophila males
###end article-title 71
###begin article-title 72
###xml 99 104 <span type="species:ncbi:4932">yeast</span>
Nuclear architecture and spatial positioning help establish transcriptional states of telomeres in yeast
###end article-title 72
###begin article-title 73
Double chromodomains cooperate to recognize the methylated histone H3 tail
###end article-title 73
###begin article-title 74
The rox1 and rox2 RNAs are essential components of the compensasome, which mediates dosage compensation in Drosophila
###end article-title 74
###begin article-title 75
###xml 42 65 <span type="species:ncbi:7227">Drosophila melanogaster</span>
Maleless, a recessive autosomal mutant of Drosophila melanogaster that specifically kills male zygotes
###end article-title 75
###begin article-title 76
###xml 40 45 <span type="species:ncbi:4932">yeast</span>
Nuclear retention of unspliced mRNAs in yeast is mediated by perinuclear Mlp1
###end article-title 76
###begin article-title 77
Drosophila sex-lethal inhibits the stable association of the 40S ribosomal subunit with msl-2 mRNA
###end article-title 77
###begin article-title 78
###xml 45 68 <span type="species:ncbi:7227">Drosophila melanogaster</span>
Lifting a chromosome: dosage compensation in Drosophila melanogaster
###end article-title 78
###begin article-title 79
Chromosome-wide gene-specific targeting of the Drosophila dosage compensation complex
###end article-title 79
###begin article-title 80
The Drosophila GAGA factor is required for dosage compensation in males and for the formation of the male-specific-lethal complex chromatin entry site at 12DE
###end article-title 80
###begin article-title 81
Nup98 is a mobile nucleoporin with transcription-dependent dynamics
###end article-title 81
###begin article-title 82
Distinct functional domains within nucleoporins Nup153 and Nup98 mediate transcription-dependent mobility
###end article-title 82
###begin article-title 83
Targeting the chromatin-remodeling MSL complex of Drosophila to its sites of action on the X chromosome requires both acetyl transferase and ATPase activities
###end article-title 83
###begin article-title 84
Direct interaction with nup153 mediates binding of Tpr to the periphery of the nuclear pore complex
###end article-title 84
###begin article-title 85
Amino acid substitutions of coiled-coil protein Tpr abrogate anchorage to the nuclear pore complex but not parallel, in-register homodimerization
###end article-title 85
###begin article-title 86
Dosage compensation in mammals: fine-tuning the expression of the X chromosome
###end article-title 86
###begin article-title 87
Unwinding dosage compensation
###end article-title 87
###begin article-title 88
###xml 69 74 <span type="species:ncbi:9606">human</span>
###xml 105 110 <span type="species:ncbi:4932">yeast</span>
mof, a putative acetyl transferase gene related to the Tip60 and MOZ human genes and to the SAS genes of yeast, is required for dosage compensation in Drosophila
###end article-title 88
###begin article-title 89
Quality control of mRNA 3'-end processing is linked to the nuclear exosome
###end article-title 89
###begin article-title 90
Translating the histone code
###end article-title 90
###begin article-title 91
JIL-1, a chromosomal kinase implicated in regulation of chromatin structure, associated with the male specific lethal (MSL) dosage compensation complex
###end article-title 91
###begin article-title 92
Regulation of chromatin structure by histone H3S10 phosphorylation
###end article-title 92
###begin article-title 93
Eaf3 chromodomain interaction with methylated H3-K36 links histone deacetylation to Pol II elongation
###end article-title 93
###begin article-title 94
Expression of msl-2 causes assembly of dosage compensation regulators on the X chromosomes and female lethality in Drosophila
###end article-title 94
###begin article-title 95
Sex lethal controls dosage compensation in Drosophila by a non-splicing mechanism
###end article-title 95
###begin article-title 96
Epigenetic spreading of the Drosophila dosage compensation complex from roX RNA genes into flanking chromatin
###end article-title 96
###begin article-title 97
Cotranscriptional set2 methylation of histone H3 lysine 36 recruits a repressive Rpd3 complex
###end article-title 97
###begin article-title 98
The Drosophila dosage compensation complex binds to polytene chromosomes independently of developmental changes in transcription
###end article-title 98
###begin article-title 99
The maleless protein associates with the X chromosome to regulate dosage compensation in Drosophila
###end article-title 99
###begin article-title 100
The NTPase/helicase activities of Drosophila maleless, an essential factor in dosage compensation
###end article-title 100
###begin article-title 101
X-chromosome-wide profiling of MSL-1 distribution and dosage compensation in Drosophila
###end article-title 101
###begin article-title 102
JIL-1 kinase, a member of the male-specific lethal (MSL) complex, is necessary for proper dosage compensation of eye pigmentation in Drosophila
###end article-title 102
###begin article-title 103
The amino-terminal region of Drosophila MSL1 contains basic, glycine-rich, and leucine zipper-like motifs that promote X chromosome binding, self-association, and MSL2 binding, respectively
###end article-title 103
###begin article-title 104
Interactions between mRNA export commitment, 3'-end quality control, and nuclear degradation
###end article-title 104
###begin article-title 105
Chromatin remodeling in dosage compensation
###end article-title 105
###begin article-title 106
Drosophila male-specific lethal-2 protein: structure/function analysis and dependence on MSL-1 for chromosome association
###end article-title 106
###begin article-title 107
The roX genes encode redundant male-specific lethal transcripts required for targeting of the MSL complex
###end article-title 107
###begin article-title 108
roX1 RNA paints the X chromosome of male Drosophila and is regulated by the dosage compensation system
###end article-title 108
###begin article-title 109
Ordered assembly of roX RNAs into MSL complexes on the dosage-compensated X chromosome in Drosophila [in process citation]
###end article-title 109
###begin article-title 110
Nuclear pore components are involved in the transcriptional regulation of dosage compensation complex in Drosophila
###end article-title 110
###begin article-title 111
Structural basis for specific binding of polycomb chromodomain to histone H3 methylated at Lys 27
###end article-title 111
###begin article-title 112
Functional integration of the histone acetyltransferase MOF into the dosage compensation complex
###end article-title 112
###begin article-title 113
The MRG domain mediates the functional integration of MSL3 into the dosage compensation complex
###end article-title 113
###begin article-title 114
###xml 41 64 <span type="species:ncbi:7227">Drosophila melanogaster</span>
Synthesis of RNA by the X-chromosomes of Drosophila melanogaster and the problem of dosage compensation
###end article-title 114
###begin article-title 115
Dosage compensation in Drosophila: an autoradiographic study
###end article-title 115
###begin article-title 116
Structure of the HP1 chromodomain bound to histone H3 methylated at lysine 9
###end article-title 116
###begin article-title 117
Structure of the chromo barrel domain from the MOF acetyltransferase
###end article-title 117
###begin article-title 118
Local spreading of MSL complexes from roX genes on the Drosophila X chromosome
###end article-title 118
###begin article-title 119
Multiple classes of MSL binding sites target dosage compensation to the X chromosome of Drosophila
###end article-title 119
###begin article-title 120
RNA polymerase II elongation through chromatin
###end article-title 120
###begin article-title 121
###xml 45 68 <span type="species:ncbi:7227">Drosophila melanogaster</span>
The male-specific lethal-one (msl-1) gene of Drosophila melanogaster encodes a novel protein that associates with the X chromosome in males
###end article-title 121
###begin article-title 122
Extent of chromatin spreading determined by roX RNA recruitment of MSL proteins
###end article-title 122
###begin article-title 123
Variable splicing of non-coding roX2 RNAs influences targeting of MSL dosage compensation complexes in Drosophila
###end article-title 123
###begin article-title 124
Mapping the dynamic organization of the nuclear pore complex inside single living cells
###end article-title 124
###begin article-title 125
MSL proteins and the regulation of gene expression
###end article-title 125
###begin article-title 126
The mle(napts) RNA helicase mutation in Drosophila results in a splicing catastrophe of the para Na+ channel transcript in a region of RNA editing
###end article-title 126
###begin article-title 127
RNA-dependent association of the Drosophila maleless protein with the male X chromosome
###end article-title 127
###begin article-title 128
Male-specific lethal complex of Drosophila targets activated regions of the X chromosome for chromatin remodeling
###end article-title 128
###begin article-title 129
MSL1 plays a central role in assembly of the MSL complex, essential for dosage compensation in Drosophila
###end article-title 129
###begin article-title 130
Switching on chromatin: mechanistic role of histone h4-k16 acetylation
###end article-title 130
###begin article-title 131
Histone H4-K16 acetylation controls chromatin structure and protein interactions
###end article-title 131
###begin article-title 132
The drosophila MSL complex acetylates histone H4 at lysine 16, a chromatin modification linked to dosage compensation [in process citation]
###end article-title 132
###begin article-title 133
Linking global histone acetylation to the transcription enhancement of X-chromosomal genes in Drosophila males
###end article-title 133
###begin article-title 134
###xml 2 7 <span type="species:ncbi:9606">human</span>
A human protein complex homologous to the Drosophila MSL complex is responsible for the majority of histone H4 acetylation at lysine 16
###end article-title 134
###begin article-title 135
Quality control of messenger ribonucleoprotein particles in the nucleus and at the pore
###end article-title 135
###begin article-title 136
Loss of the modifiers of variegation Su(var)3-7 or HP1 impacts male X polytene chromosome morphology and dosage compensation
###end article-title 136
###begin article-title 137
The language of covalent histone modifications
###end article-title 137
###begin article-title 138
Stable chromosomal association of MSL2 defines a dosage-compensated nuclear compartment
###end article-title 138
###begin article-title 139
###xml 86 109 <span type="species:ncbi:7227">Drosophila melanogaster</span>
Functional redundancy within roX1, a noncoding RNA involved in dosage compensation in Drosophila melanogaster
###end article-title 139
###begin article-title 140
Chromatin elongation factors
###end article-title 140
###begin article-title 141
###xml 76 81 <span type="species:ncbi:4932">yeast</span>
Nuclear pore association confers optimal expression levels for an inducible yeast gene
###end article-title 141
###begin article-title 142
Chromatin mechanisms in Drosophila dosage compensation
###end article-title 142
###begin article-title 143
Stable mRNP formation and export require cotranscriptional recruitment of the mRNA export factors Yra1p and Sub2p by Hpr1p
###end article-title 143
###begin article-title 144
A Drosophila Tpr protein homolog is localized both in the extrachromosomal channel network and to nuclear pore complexes
###end article-title 144

